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“I have been impressed with the urgency of doing. Knowing is not enough; we must apply. 
Being willing is not enough; we must do. ” 
- Leonardo da Vinci 
 
 
 
 
 
 
      
 
 
ABSTRACT 
Background: Nutritional iron deficiency is the number one cause of anemia worldwide. Iron 
deficiency anemia has morbidity and mortality effects borne predominantly by 
premenopausal women and children living in South Asia and sub-Saharan Africa. 
Community-based interventions have successfully addressed several global health problems, 
although there is limited evidence of their effectiveness for childhood anemia. The overall 
aim of this thesis was to test the hypothesis that community-based education and counseling 
delivered to mothers of anemic children by health workers would improve anemia cure rates.  
Methods: The thesis included 4 studies, two of which (Study I and II) were cross sectional 
studies constituting the background for intervention design. The social cognitive theory 
framework guided the development of the intervention, which consisted of five monthly 
education sessions delivered by a health worker covering: i) maternal anemia awareness, ii) 
adherence to iron treatment, iii) dietary modification, and iv) hygiene and sanitation. The 
intervention was evaluated in a pragmatic mixed methods trial conducted among 12-59 
month old children from 55 villages of the Chamarajnagar district, Karnataka. Villages (and 
health workers therein) were randomly assigned 1:1 to provide anemic children either the 
usual iron treatment alone or the same treatment complemented by education and counseling 
of their mothers/caregivers. The primary trial outcome was the difference in anemia cure 
rates (return of hemoglobin to ≥11g/dL) at the end of six months. Thematic analysis with the 
framework method was utilized to understand health workers acceptance of the intervention 
and their perceptions of obstacles and opportunities connected to its implementation (Study 
III). A cluster randomized trial contrasting intervention to usual treatment condition was used 
to study the effects of the intervention (Study IV). The statistical analysis was conducted 
taking into account the cluster design,  using multilevel regression. 
Results: A high prevalence of childhood anemia was found in healthy rural toddlers (75%) 
mainly due to iron deficiency anemia (Study 1). Coverage of children with iron supplements 
from the national anemia control program was low (Study II). Health workers delivering the 
intervention found it acceptable and feasible to implement during routine work activities 
(Study III). After six months, anemic children in the intervention group had significantly 
higher anemia cure rates compared with anemic children in the usual treatment group (55.5% 
vs. 41.4%; relative risk ratio 1.33, confidence interval [CI], 1.04-1.69). The proportion of 
anemic children consuming >75% of prescribed iron was higher in the intervention group 
compared with the usual treatment group (61.7% vs. 48.4%; p=0.001). The results indicated 
that seven mothers needed to be counselled in order to cure one anemic child (Study IV). 
Conclusions: The studies included in this thesis indicate that mother/caregiver education 
achieved a perceivable improvement to the cure rate of nutritional iron deficiency anemia in 
children from rural India, probably through improved adherence to iron treatment. High 
intervention acceptance at the health worker level suggests that wider implementation is 
possible. Scientific evaluations of community-based interventions are feasible even in rural 
disadvantaged environments.  
Keywords: Childhood anemia, iron deficiency, lay health workers, iron supplements, India, 
cluster randomized controlled trial 
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 GLOSSARY OF TERMS 
 
Childhood anemia: Hemoglobin less than 11 g/dL in children aged 6 mth-6 years. 
 
Iron deficiency: Total body iron below the lower limits of normal with preservation of levels 
of erythroid iron. 
 
Iron-deficiency anemia: Depressed levels of both total body iron and erythroid iron evidenced 
by the development of anemia. 
 
Functional iron deficiency: Insufficient mobilization of erythroid iron in the presence of 
increased demand, as occurs after treatment with erythropoiesis-stimulating agents. 
 
Iron-restricted erythropoiesis: A reduced supply of iron for the purpose of erythropoiesis, 
regardless of the level of iron stores, which are usually replete. 
 
Anemia of inflammation: Multifactorial anemia associated with increased cytokine 
production, up-regulation of hepcidin, and abnormal iron homeostasis. 
 
Pragmatic trial:  Trials designed to show the real-world effectiveness of the interventions or 
health care innovations in broad patient groups. 
 
Effectiveness: the degree of beneficial effect of a treatment or preventive measure in “real 
world” settings. 
 
Efficacy: the degree of beneficial effect of a treatment or preventive measure in pure 
experimental conditions. 
 
Lay health worker: A health worker performing health care delivery functions trained in 
some way in the context of an intervention, but not receiving formal professional training or a 
tertiary education degree. 
 
Integrated Child Development Services (ICDS): A large national program for the promotion 
of the mother and child health and development. Beneficiaries are children below 6 years, 
pregnant and lactating mothers, and other women in the age group of 15 to 44 years. The 
scheme covers services including supplementary nutrition, immunization, health check-up, 
referral services, nutrition and health education, and pre-school education. The distribution of 
  
iron and folic acid tablets and vitamin A is also undertaken to prevent iron deficiency anemia 
and vitamin A deficiency.  
 
Anganwadi day care center (ADC): Anganwadi means courtyard and refers to the village 
child-care center. A typical rural ADC employs an ICDS-funded ADC lay health worker 
providing child-care and serving a village with a population of about 1000 (with 10-15% 
aged 1·0-6·0 years). Usually it is a simple single room or two roomed facility located in the 
village, made according to guidelines laid by ICDS. 
 
National Nutritional and Anemia Control Program: A national program implemented through 
the Primary Health Centers aiming to decrease the prevalence and incidence of anemia in 
women of reproductive age and other vulnerable groups. 
 
National Iron Plus Initiative (NIPI): A national program launched by the Ministry of Health 
and Family Welfare in 2013 as a comprehensive strategy to combat the public health 
challenge of iron deﬁciency anemia prevalent across the life cycle. 
 
Iron and folic acid (IFA): Iron and folic acid tablets, each containing 20 mg of elemental iron 
and 0.5 mg of folic acid. 
 
  
 LIST OF ABBREVIATIONS 
 
WHO World Health Organization  
ID Iron deficiency 
IDA Iron deficiency anemia 
IFA Iron and Folic Acid 
NRHM National Rural Health Mission 
NNACP National Nutritional and Anemia Control Program 
NIPI National Iron Plus Initiative 
ADR Adverse Drug Reaction 
CI Confidence Interval 
DSMB Data and Safety Monitoring Board 
Hb Hemoglobin 
HR Hazard Ratio 
RR Relative Risk 
OR Odds Ratio 
RCT Randomized Controlled Trial 
cRCT Cluster Randomized Controlled Trial 
SD Standard Deviation 
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1 INTRODUCTION 
 
1.1 ANEMIA: HISTORICAL BACKGROUND 
Despite several prescient observations of anemia-associated maladies treatable with iron 
made by the medical community as early as in the 17th century (chlorosis, microcytic anemia 
with achlorhydria, post cricoid webs with anemia), an underlying nutritional problem was not 
recognized until two centuries later. In the late 1920’s, Helen Mackay (Figure 1) observed 
that the late anemia of infancy (after the physiological post-natal hemoglobin fall) was 
preventable with iron1. Mackay noted that anemia diminished in iron-supplemented infants 
compared with infants not receiving supplementary iron, when iron was started 6 months 
after birth. These seminal observations clearly established a link between nutritional iron 
deficiency and anemia. Mackay’s studies demonstrated the nutritional vulnerability of 
premature infants, drawing conclusions that the anemia of late infancy resulted from 
insufficient dietary iron and could be eliminated by supplementary iron. Her recommendation 
that iron should be given to non-breastfed infants from the first months of life because this 
can yield higher levels of hemoglobin later in infancy remains valid even today.  
 
Almost 100 years after Mackay began her studies, nutritional iron deficiency anemia (IDA) is 
still the number one form of anemia worldwide. Unsurprisingly, the principal clinical concern 
with iron nutrition remains the same as it did before the role of iron was delineated, namely 
detection, treatment and prevention of anemia in vulnerable groups. Global inequalities in 
anemia prevalence reflect the stark differences between developing and developed countries 
and the differential exposure to the social determinants of anemia. It is in this context that the 
thesis should be read. Its focus is on childhood iron deficiency anemia, a condition 
successfully controlled by prevention programs in other settings, but still unchecked in India.  
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3 
1.2 ANEMIA IN CHILDREN: A GLOBAL HEALTH PROBLEM 
1.2.1 Pathogenesis of iron deficiency anemia 
Iron is the fourth most common ground element in nature and forms an essential component 
of hemoglobin, myoglobin, enzymes, and cytochromes necessary for oxygen transport and 
cellular respiration. Iron is also critical for optimal physical growth, neurogenesis and 
cognitive function2,3. Uptake, recycling and storage of iron in the body is a tightly regulated 
process controlled by a series of iron regulatory proteins (Figure 2)4.  
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4 
Cellular iron uptake (heme iron or non heme iron) occurs in the proximal duodenum via 
cellular transport proteins, the dimetal transporter (DMTP-1) and a yet to be identified heme 
transporter. Gut iron absorption, normally ~5% at steady state body iron stores can increase to 
30% in the presence of iron deficiency anemia4. Since there is no bodily iron excretion 
mechanism, absorption of iron from the intestinal epithelium into the blood stream is tightly 
regulated by ferroportin, currently the only known cellular iron export protein. Hepcidin, the 
principal regulator of iron homeostasis, controls ferroportin expression on intestinal 
epithelium and reticuloendothelial cells by inducing its degradation5.  
 
Upstream signals triggering hepatic hepcidin release include hypoxia (HIF 2alfa), 
inflammation (IL-6)6, and erythroferrone7, a protein recently described in mice. In states of 
iron deficiency and iron deficiency anemia, hepcidin levels are extremely low permitting 
greater ferroportin expression and consequently increased iron import from intestinal 
epithelial cells into the blood stream. Iron thus absorbed, gets bound to transferrin and is 
utilized by erythrocytes produced in the bone marrow. Preexisting iron from senescent 
erythrocytes undergoing phagocytosis by reticuloendothelial macrophages is exported via 
macrophage ferroportin to developing marrow erythrocytes. During inflammation, hepcidin 
levels are high, ferroportin expression is low and iron is neither exported from the intestinal 
epithelium into the blood nor exported out from macrophages to newly synthesized 
developing erythrocytes, resulting in iron-restricted erythropoiesis. Under the influence of 
competing signals (anemia, iron deficiency, and infection) hepcidin controls cellular uptake 
of supplemental/therapeutic iron8.  
 
From a biological perspective, iron deficiency anemia occurs either due to decreased 
erythrocyte production e.g. in nutritional iron deficiency (ineffective erythropoiesis); or 
increased loss of erythrocytes through increased destruction (hemolysis) or blood loss 
(bleeding); or a combination of the two (Table 1)4.  




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It is important to recognize that not all cases of anemia are due to iron deficiency anemia, 
although much of the public health literature fails to make this distinction9. It has been 
estimated that about half of the anemia burden worldwide is due to nutritional iron 
deficiency10, with and without other coexistent deficiencies (folate, vitamin B12 and vitamin 
A). Other factors contribute to the etiology of anemia, including mineral and essential 
element deficiencies, genetic hemoglobin disorders, and infectious diseases11. Inflammation, 
and chronic illness such as cancer and renal disease are also contributory causes although 
these are more prevalent in adults11,12. Accurately defining the proportion of anemia that 
results from nutritional iron deficiency would greatly clarify the beneficial effects of 
interventions designed to specifically target this process. In spite of its multifactorial 
etiology13-19, iron deficiency anemia is the predominant form of anemia in Indian 
children20,21.  
 
 
1.2.2 Global burden of disease due to anemia 
 
The World Health Organization (WHO) currently defines anemia based on thresholds set at 
the fifth percentile of hemoglobin in a normal population appropriately adjusted for age and 
sex22. According to this definition, it is estimated that 25% of the world’s population (1.62 
billion people) is anemic. Preschool children (47.4%) and pregnant women (41.8%) have the 
highest anemia prevalence overall23. In terms of geographic regions, Africa (67.6 and 57.1%) 
Physiologic causes  Infancy, adolescence, pregnancy 2nd and 3rd trimester  
Insufficient intake  Malnutrition, vegetarians, vegans, and iron poor food  
Decreased iron absorption Drugs e.g. proton pump inhibitors, dietary iron chelators, disease 
conditions e.g. Inflammatory bowel disease, tropical sprue, 
infections e.g. H. pylori, gastric surgery, and genetic causes e.g. 
iron refractory iron deficiency anemia 
Increased iron loss Gastrointestinal (e.g. worm infestations) and genitourinary 
bleeding (e.g. menstrual blood loss) bleeding from hereditary 
disorders and phlebotomy from routine blood donations 
Chronic diseases Chronic kidney disease, cancer related anemia, infections (e.g. 
tuberculosis) inflammatory disease related anemia, heart failure 
associated anemia, obesity related anemia, anemia of the elderly 
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and Southeast Asia (65.5 and 48.2%) have the highest burden of anemia in preschool children 
and pregnant women, respectively (Figure 3)23,24.  
 
 
 
Globally, anemia accounted for 68.4 million years of life lived with disability in 2010 i.e.  for 
8.8% of all disease related disability lived years10. In 2013, iron deficiency anemia was the 
leading cause of years lived with disability among children and adolescents, affecting 619 
million individuals25. Notwithstanding this global picture, childhood anemia receives little 
attention in the public health domain.  
 
Global anemia prevalence has remained unchanged over the past two decades according to 
trends in hemoglobin distribution between 1995-2011, emphasizing the scale and pernicious 
nature of this problem (Figure 4)10,26. During this period, preschool age children had the 
highest anemia prevalence in all geographic regions, the highest mean severity in all low and 
middle-income regions, and were the only age group to demonstrate an increase in anemia 
prevalence.  
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In absolute terms, India is home to one third of the worlds’ anemic population, with over 70% 
affected women and children, which translates to over 100 million preschool children with 
IDA10.  
 
Several factors are associated with the development of iron deficiency anemia11,27. Inadequate 
iron intake particularly among people in low-income (especially rural) settings may be due to 
limited access to quality nutrition, iron fortified foods, knowledge, appropriate health care, 
hygiene and sanitation. Poor sanitation promotes bacterial and parasitic infections (malaria) 
and infestation with soil parasites (hookworms). At the family level, physiological 
vulnerability of women due to early onset pregnancy, multiparity and inadequate birth 
spacing result in maternal anemia and increase the risk of childhood nutritional iron 
deficiency anemia.  
 
All the above are influenced at a more proximal sociopolitical and geopolitical level by 
factors affecting health care access (roads and transportation), cultural sanitation norms, 
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8 
agricultural practices, anemia control policies, and ultimately, the prevailing economic, 
political, and environmental conditions (Figure 5).  
 
 
1.2.3 Childhood anemia prevalence in India 
 
The fifth percentile of plasma hemoglobin concentration in children 6–59 months is <11 g/dL 
and forms the basis for the WHO recommended diagnosis of anemia in children22. Using this 
definition, two population-wide National Family Health Surveys in 1999 (NFHS 2) and 2006 
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9 
(NFHS 3) showed a rise in anemia prevalence from 75% to 79% in 6-35 month old children 
in 28 Indian states28. This increase was largely due to a rise in rural anemia prevalence 
(Figure 6)28.  
    
 
Anemia is also classified according to its population prevalence as a mild (0-20%), moderate 
(21-40%), or severe (>40%) public health problem23. With over 40% of its preschool children 
anemic, India and its South Asian neighbors have a severe public health problem (Table 2). 
Of note, community-based interventions in neighbouring Bangladesh have been shown to 
improve nutrition outcomes in women and children29. 

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Country 
 
Estimated proportion 
preschool children with 
anemia (Hb <11 g/dl) 
Confidence 
intervals 
*Category of public 
health significance 
Bangladesh 47.0 42.9–51.1 Severe 
Bhutan 80.6 67.3–89.3 Severe 
India 74.3 73.4–75.1 Severe 
Nepal 78.0 76.1–79.8 Severe 
Pakistan 50.9 49.2–52.6 Severe 
Sri Lanka 29.9 27.0–33.0 Moderate 
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1.2.4 Factors influencing childhood iron status 
 
Several antenatal and perinatal factors affect the accumulation and eventual body iron stores 
of the child setting the stage for adequate iron status at birth30. Soon after birth, infant iron 
status is determined by four factors: the iron the infant is born with, the infant’s postnatal iron 
needs, the external sources of bioavailable iron, and iron losses (Figure 7).  
 
 
Among contextual factors, maternal malnutrition and anemia during pregnancy play a key 
role in determining the child’s iron status in this region. Maternal nutritional iron deficiency 
coupled with sociocultural factors (high anemia prevalence in adolescence, early marriage, 
and low birth spacing) affects the child’s iron status in-utero. Rural Indian diets consist of 
predominantly non-heme proteins and high phytate containing cereals, both factors seriously 
limiting gastrointestinal iron absorption. In addition to dietary factors a high burden of 
infectious diseases also possibly explains the prevalence of iron deficiency anemia in rural 
Indian children. India’s burden of childhood infectious disease is high31,32, with a large 
number of under-five children reporting an acute infection in the 2 weeks preceding the 
NFHS 3 survey [acute respiratory infections (6%), diarrhea (9%) and fever (15%)]28. 
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Children with infections have high serum hepcidin level, which can limit absorption of 
dietary and supplemental iron from the duodenum (see Figure 2)8,33.  
 
 
1.2.5 Consequences of childhood iron deficiency anemia  
 
Iron deficiency anemia results in protean clinical manifestations. Symptoms are usually mild 
most children and adults appear to disregard or seem minimally affected as they acclimatize 
to the resultant hypoxia. Young children are most affected in the long-term by the detrimental 
effects of iron deficiency anemia3,34,35. 
Clinical consequences 
Symptoms of iron deficiency anemia in both children and adults are generally non-specific 
resulting from impaired tissue oxygen delivery and may include weakness, fatigue, difficulty 
concentrating, or decreased attention, lethargy, and irritability. However, iron deficiency 
anemia has also been associated with ischemic stroke in otherwise healthy children36. 
 
A case-
control study found that among 15 cases of stroke in otherwise healthy children ages 12 to 38 
months, eight had iron deficiency anemia (53%) compared with 13 of 143 (9%) matched 
healthy controls suggesting that children with iron deficiency anemia are at increased risk for 
stroke37. In adults, the clinical effects, especially when severe, are correlated with increased 
risk of preterm labor, low birth weight38, and maternal mortality and may predispose to 
infection and cardiac morbidity4. Iron is important for immune function39 and its deficiency 
may increase the frequency of infection40 but whether iron deficiency and iron deficiency 
anemia are associated with an increased risk of infections due to compromised cellular or 
humoral immune responses has been harder to establish in human studies33,41.  
 
Cognitive effects 
Iron deficiency anemia is thought to have profound effects on childhood cognitive and 
psychomotor development34,35,42-46. A review of 15 studies found that infants with iron 
deficiency anemia had cognitive test scores 6 to 15 points lower and motor test scores 9 to 15 
points lower than iron-sufficient infants3. The effect of iron deficiency anemia in infancy and 
long-term developmental outcomes was evaluated in 114 healthy and relatively well-
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nourished Costa Rican children from ages 12 to 23 months to age 19 years34,45. Cognitive 
delays and psychomotor retardation were significantly greater in children having iron 
deficiency anemia after adjusting for socioeconomic status34. There is inconsistent evidence 
suggesting reversibility of these cognitive and psychomotor changes in randomized trials of 
iron treatment3,35,47-49.  
 
Mortality 
Longitudinal studies that report death seldom incorporate specific biomarkers of iron status, 
such as serum iron, ferritin or transferrin receptor. Therefore, it is difficult to determine the 
iron deficiency anemia (rather than anemia due to other causes) and child mortality is difficult 
to characterize. Consequently, the contribution of anemia to mortality is estimated assuming 
that low hemoglobin concentrations in children reflect an iron deficit in approximately half of 
the cases10. Making such assumptions, a recent meta-analysis of nearly 12,000 children aged 
28 days to 12 years, from six African countries demonstrated a combined odds ratio of 0.76 
(CI, 0.62-0.93), indicating that for every 1 g/dL rise in hemoglobin, the risk of mortality fell 
by 24%50. Although these studies were conducted in predominantly malaria endemic regions, 
mortality was similar in cases of anemia that were not attributable to malaria. Thus, indirect 
evidence suggests that anemia per se contributes to childhood mortality. 
 
Morbidity, social and economic impact 
Among health problems causing the greatest disability in India, nutritional iron deficiency 
anemia was ranked the top in 2016, leading to the loss of over 18% of all disability adjusted 
life years51,52. More recent economic estimates in a 6 and 59 month old Indian birth cohort 
affected by iron deficiency anemia amount to intangible costs of 8.3 million disability 
adjusted life years and production losses of 24,001 million USD in 201353. Both intangible 
costs and production losses as a result of future losses due to cognitive delays arise in all 
socio-economic groups, but the largest share of these effects occurring in poor rural 
households. Iron deficiency anemia was the leading cause of years lived with disability 
among children and adolescents, affecting 619 million in the year 201325. The combination of 
iron deficiency anemia with a health system unable to provide optimal anemia preventive 
care (see section 1.3.2) is a key obstacle to optimizing health in rural Indian children. 
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1.2.6 Treatment of iron deficiency anemia 
 
Treatment of anemia follows the assessment of anemia severity and of the state of tissue 
oxygenation. In an emergency situation, blood transfusions can be indicated, but in all cases, 
identification of etiology of anemia and treatment of the underlying cause (nutritional 
deficiency, infectious disease, and infestation) are warranted. The scope of treatment is to 
replenish micronutrient stores to normal levels and prevent future recurrence of micronutrient 
loss or deficiency through targeted interventions delivered to affected individuals throughout 
the life cycle54. 
 
Iron deficiency anemia in children is typically treated with oral iron. For infants and young 
children, the recommended dose for treating iron deficiency anemia is 3-6 mg/kg elemental 
iron per day
 
in three daily doses, although some studies have found that once-daily dose 
results in similar improvement as two to three doses daily and does not significantly 
increase adverse effects55. Recent studies of single dose and alternate day dosed iron show 
improved iron incorporation into erythrocytes and fewer associated adverse effects that 
could improve adherence56. Treatment for 4 weeks generally results in an increase in 
hemoglobin of at least 1 g/dL and generally lasts for several months; the duration of 
treatment depends on the severity of anemia54. Treatment includes an additional 3 months 
of oral iron after normalization of hemoglobin to adequately replenish body iron stores. In 
rare cases of intolerance or clinical unresponsiveness to oral iron (iron refractory iron 
deficiency anemia), intravenous iron may provide optimal therapeutic responses4. 
 
Adverse events are typically limited to gastrointestinal tract symptoms, such as constipation, 
which appear to be directly related to the dose of elemental iron. Increasing the dose over 
several days, reducing the amount of elemental iron taken daily, or taking the iron with food 
may improve these symptoms. Urine and stool may be darker in color when taking iron 
(usually black), and liquid formulations can cause temporary gray staining of teeth and gums. 
Iron can cause important interactions with several drugs and can be fatal in overdose in 
children warranting the use of child proof IFA dispensation containers. 
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The safety of childhood population wide iron supplementation was questioned by a large 
cluster randomized placebo controlled trial in a malaria endemic region of Africa57 but the 
absence of similar finding from other studies conducted in both malaria endemic and 
nonendemic areas have been reassuring58-61. Due to high baseline iron deficiency prevalence 
and low malaria prevalence in the study area, these risks appear to be largely theoretical. 
 
1.3 PUBLIC HEALTH INTERVENTIONS FOR ANEMIA CONTROL 
 
1.3.1 Interventions for nutritional anemia: what works  
The WHO recently prioritized reduction of global anemia prevalence in women by 2025 and 
the United Nations Development Programme sustainable development goal number two 
actively advocates better control of childhood malnutrition underscoring the notion that 
nutritional anemia is a high priority52,62,63. Yet, judging by trends in global anemia 
prevalence26, the probability of achieving these goals is low, prompting an examination of 
successful anemia control efforts in countries other than India. 
 
Broad based public policy interventions targeting nutrition 
At the broad policy level, improving socioeconomic status, addressing food insecurity, and 
food fortification programs have decreased maternal and child undernutrition and anemia 
prevalence52,64,65. Integrated public health nutrition interventions aimed at improving 
nutritional status in vulnerable groups showed the greatest effect in populations with 
significant income, health and nutrition disparities66-68. Amongst these are interventions 
directed at nutrition education69, dietary modification, food provision/supplementation66,67,70, 
agricultural interventions including bio-fortification71, multiple micronutrient 
supplementation72 and food fortification52,73-75. Aside from the integrated child development 
scheme (ICDS)70,76, there are remarkably few broad based policy efforts addressing anemia in 
India, where anemia prevention activities also include fortification of staple foods with iron. 
Unfortunately, limitations in rice fortification technology and low population level 
acceptance of fortified foods make such programs strategically less appealing. Furthermore, 
food fortification programs efforts are primarily aimed at the urban populations with limited 
reach to rural communities75,77.  
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Policies addressing iron and multiple micronutrient deficiencies 
Specific public health programs include population-wide iron supplementation targeting high 
risk groups, a strategy that has led to overall anemia risk reduction by 49% and iron 
deficiency risk reduction by 74%12,78,79. Use of multiple micronutrient supplementation has 
been shown to improve hemoglobin and reduce anemia risk in children by 57%42. However, 
when compared with iron alone, multiple micronutrient supplements add little benefit to 
hemoglobin responses42,72. Although overwhelming scientific evidence demonstrates the 
effectiveness of targeted iron supplementation in reducing childhood anemia prevalence 
worldwide80,81, this strategy has yielded lower than expected results in India. The reasons are 
explored in greater detail in the next section. 
 
Interventions aiming at improving hemoglobin levels 
Periodic deworming has no obvious effect on hemoglobin response82, but programs that 
screen and detect worm infestation followed by a single treatment of deworming show 
improvements of hemoglobin levels83. Currently, population-wide deworming on a biannual 
basis for children above 2 years is widely practiced in India and continues to have policy 
support84. Malaria is nonendemic in many areas of India and specific interventions tend to 
focus on vector control combined with effective diagnosis and treatment of individual cases75. 
The contribution of common infections to anemia burden appears to be largely ignored or 
underestimated. Effective implementation of ongoing community interventions directed at 
treatment and prevention of these diseases (IMNCI, RNTCP, and WASH)1 could help 
address the overall burden of non-iron deficient anemia resulting from infectious diseases.  
Genetic hemoglobin disorders affecting anemia prevalence are beyond the scope of the 
current work and strategies for their treatment and control, integral components of childhood 
anemia prevention are reviewed elsewhere85,86. Currently, there are ongoing efforts to 
integrate hemoglobinopathy screening in areas of high prevalence but these are few and 
require national efforts87. While important, these interventions do not specifically target the 
major cause of mild to moderate anemia in children: iron deficiency.  
 
                                                
1 IMNCI, Integrated Management of Neonatal and Childhood Illnesses; RNTCP, Revised National 
Tuberculosis Control Program; WASH, Water Sanitation and Hygiene.  
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1.3.2 Public health measures for anemia control in India  
Public health anemia control activities in India began in 1970 with the nutritional anemia 
prophylaxis program and were re-designated as the National Nutritional and Anemia Control 
Program (NNACP) in 1991, when they incorporated both anemia prevention and treatment 
activities. However, decades of efforts with childhood iron supplementation and treatment of 
anemic children have yielded a reduction in anemia prevalence which is lower than expected 
reductions.  Possible reasons for this include poor health infrastructure, inadequate funding of 
the program and other health system factors ultimately leading to insufficient coverage of 
children with IFA77,88. In fact, nationwide surveys demonstrate unacceptably low coverage of 
both women and children, important target beneficiaries of the program28. Anemia case 
detection is also limited by low sensitivity screening strategies (e.g. visual inspection of 
mucous membranes for anemia screening by community health workers) which also hamper 
program effectiveness77.  
 
To date, the anemia control program is implemented largely by the Accredited Social Health 
Activist (ASHA) from the primary health center, which serves a population of 30,000 
individuals (approximately 20-30 villages). Among diverse health promotion activities,  
anemia control efforts include: (a) promoting the consumption of iron rich foods, (b) 
providing IFA tablets, and (c) identifying and treating severe anemia. Case detection is 
targeted to groups at high risk for anemia (women, pregnant women, adolescent girls and 1-5 
year-old community dwelling children). Unfortunately, ASHA workers are non-salaried 
employees and do not receive financial incentives for anemia control work unlike the other 
health promotion work activities (e.g. providing primary health care services for pregnant and 
antenatal women). Thus, in addition to the limitations identified above, lack of financial 
incentives and low health worker motivation levels adversely affects childhood anemia 
control. IFA adherence in young beneficiaries, another important understudied aspect that 
affects program success will be explored in greater detail in the next two sections.  
 
In 2013, the National Rural Health Mission and the Ministry of Health and Family Welfare 
consulted with domain experts and released new anemia control guidelines entitled National 
Iron Plus Initiative (NIPI; Appendix 1)84. These guidelines are a major step that begin to 
address several of the limitations described above. First, they recommend financial incentives 
for ASHA workers specifically for anemia control activities, simplification of iron 
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supplementation regimens, and provision of age appropriate iron formulations for children 
(liquid iron formulation that can facilitate adherence by small children). Second, they 
recognize the potential value of motivating behavior change (dietary habits and adherence), 
social marketing of IFA to improve adherence, and the utility of LHW education and 
counseling for anemia. Unfortunately, the guidelines fail to prioritize the detection/treatment 
of anemic cases and lack a statewide/national implementation strategy.  
 
1.3.3 Community-based interventions delivered by lay health workers 
 
Lay health workers are usually the point of first contact and deliver important health services 
to rural communities in India. In this thesis, the term lay health worker is used synonymously 
with the anganwadi day care center worker (a health worker that is quite distinct from the 
ASHA worker). The anganwadi day care center health worker is a salaried employee of the 
ICDS who is administratively responsible for the village anganwadi day care center and 
provides care for children in her own village. The anganwadi day care center worker is thus 
uniquely poised to provide health education for mothers during their routine consultations 
and to closely monitor nutritional health outcomes in the child. Previous studies have shown 
that lay heath workers optimize maternal and child health outcomes by facilitating nutrition 
education, immunization uptake, breast and complementary feeding practices, adherence to 
iron supplementation and reducing infectious disease mortality68,82,89-96.   
 
Studies from Bangladesh97 and Indonesia68 indicate that lay health workers play a key role in 
preventing childhood anemia. In rural Indonesia, lay health workers enhanced intervention 
uptake at the community level and better performing lay health workers achieved better 
childhood anemia reduction outcomes68.  Community-based interventions led by lay health 
workers have effects that are moderated by social and environmental conditions acting at 
different levels, including interpersonal (family, peers, and social networks), community (day 
care center and school), and governmental (local, state, and national policies)98. These 
interventions have the advantage of achieving parental knowledge and practice changes that 
are usually affordable for the target audience, therefore potentially transmissible to the next 
generation and sustainable in the long term99. 
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1.3.4 Improving adherence to IFA among children’s caregivers 
 
In medical sciences, there is an abundance of studies about adherence to prescribed treatment 
among patients with chronic diseases100,101. In contrast, factors motivating adherence 
behaviors of mothers/caregivers who receive “treatment” for their healthy children from a 
community health worker are less predictable102-107. Moreover, few studies have actually 
evaluated adherence to iron supplements in preschool children107-109. Most of the published 
studies evaluated adherence among women and adolescent girls56,104,109-114 and have not 
investigated whether mothers adhered to instructions about giving iron to their children.  
 
Knowledge and use of supplements 
Large studies have evaluated perceptions of pregnant women about anemia and iron 
deficiency in limited resource settings including India110,115. Pregnant women recognized IFA 
tablets and took them as instructed but usually did not know why they were prescribed. 
Among pregnant women, improving knowledge about anemia and its treatment increases 
their adherence to iron supplements116. Contrary to common beliefs, relatively few mothers 
report decreased adherence due to side effects from iron supplements (~30%)115. Health 
system factors, such as inadequate or fluctuating supplies of iron tablets also diminish 
adherence115. Based on the above mentioned studies in women and adolescent girls, it can be 
hypothesized that interventions to educate mothers about childhood anemia may enhance 
adherence in administering iron supplements to their children. 
 
Barriers and facilitators 
Studies have showed that major barriers for pregnant women taking iron supplements were 
poor access to iron (inadequate supplies), side effects (mostly gastrointestinal), fear (large 
baby, difficult delivery, harm to the baby), recovery (feeling better so no longer needing the 
tablets) and resistance (forgetting or just not wanting to take tablets)106,115,117. Facilitators 
included alleviation of anemia symptoms, appreciation of benefits for the growing fetus, and 
a subsequent increased demand for prevention and treatment of anemia106. Literacy appears 
to influence IFA uptake with educated mothers in some cases actually demanding their share 
of iron from lay health workers115.  
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Modifiers of adherence behaviors in community interventions 
Combining micronutrient interventions with food supplementation, appears to facilitate 
adherence which is greater among less educated mothers than more educated mothers103. 
Involvement of lay health workers facilitates intervention uptake and plays an important role 
in influencing health-seeking behaviors of low socioeconomic status communities68. 
Contextual and health system factors also affect adherence behaviors102,104,110,118 profoundly 
influencing intervention implementation and eventual health outcomes. 
 
 
In summary:  
 In the Indian context there is a wide gap of knowledge  concerning:  estimates of  community 
level anemia prevalence in children using accurate diagnostic tests;  coverage of children with 
IFA by anemia control programs;  development and scientific evaluation of  novel 
community-based public health intervention specifically targeting mothers/caregivers of 
anemic children. The studies in this thesis address the gaps identified above and develop an 
intervention to improve the cure rate of anemic children. 
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2 AIMS 
 
2.1 OVERALL RESEARCH QUESTIONS 
 
• What are the determinants of childhood anemia in community dwelling children in 
rural provinces of South India (Study I)?  
 
• What is the coverage of rural children with iron supplements by the national anemia 
control program (Study II)?  
 
• What effect does a community-based parental educational intervention delivered by 
lay health workers have on anemia cure rate in rural children, when added to usual 
treatment (Study IV)?  
 
• What are the experiences of community lay health workers delivering such an 
intervention (Study III)? 
 
2.2 RATIONALE FOR THE THESIS AND CONCEPTUAL FRAMEWORK 
Studies I and II provided the background for intervention development through the estimation 
of the prevalence and etiology of anemia in rural children as well as of the coverage of these 
children with iron supplements according to the national anemia control program (see 
overview of studies 1 and II shown below). 
Childhood anemia control in India has had limited success for reasons including insufficient 
parental awareness of anemia, insufficient coverage of children with IFA, inadequate 
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program support by community health workers, and lack of adherence to iron 
supplementation by children’s families. Lay health worker supported community-based 
interventions have previously improved maternal and child health outcomes64,119 and anemia 
specific outcomes68. Remarkably few community-based interventions have used lay health 
workers as interventionist’s to achieve health improvement in India and not a single one has 
examined childhood anemia programs69,120. We hypothesized that an educational and 
counseling intervention delivered by a lay health worker, with a strong parental component 
specifically directed at reducing knowledge gaps among mothers, at improving parental self-
efficacy, and at enhancing adherence to IFA delivery to the anemic child would achieve 
better anemia cure rates than usual treatment (Figure 8).  
 
1
2 
 
2.3 METHODS 
2.3.1 Intervention theoretical basis and design 
 
Theoretical frameworks in the planning stage of the intervention were developed according to 
Fraser et al and optimized in a stepwise manner121,122. In the Problem Theory, mother’s 
knowledge, attitude, beliefs, care and control, role model, willingness to change, and parental 
self-efficacy were identified as malleable factors in order to influence the hygiene, dietary 
habits, and adherence to IFA supplements in their children123. The Social Cognitive Theory 
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framework largely guided the intervention design, wherein at least two principal sources of 
enhancement of self-efficacy were identified: verbal persuasion and performance 
accomplishment124. Education of mothers about anemia, nutrition, IFA supplementation, and 
hygiene could foster the perception that their actions would control anemia in their children. 
This would lead to positive expectations about their children’s health outcomes, which, along 
with LHW facilitation of learning and positive reinforcement would improve IFA adherence 
in the child. Additional details about the intervention are provided in the methods section. 
Evaluating the effectiveness of the outcome of this intervention scientifically led to the 
production of the study protocol (Appendix 2). 
2.3.2 Pragmatic trial design using mixed methods  
 
The effectiveness of the intervention was evaluated in a pragmatic trial based on a cluster 
randomized design (Figure 9; Study IV) the protocol of which is shown in Appendix 2. By 
measuring the degree of beneficial effect under “real world” clinical settings pragmatic 
trials tend to emphasize effectiveness rather than “efficacy”125. 
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We believe that this approach would provide the most relevant information for decision 
makers. Since community sensitivities, intervention design aspects, contextual and health 
system factors profoundly influence lay health worker performance, we used qualitative 
methods to understand lay health worker perspectives regarding intervention acceptability 
and implementation (Study III)126.  
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3 METHODS 
 
3.1 THESIS OVERVIEW 
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3.2 STUDY SETTING 
 
Studies I and II were conducted as situational analyses of childhood anemia in healthy rural 
community dwelling children from rural Karnataka, South India. Studies III and IV, were 
conducted in the Chamarajnagar district of South India (Figure 9). The study district is 
located in the south Indian state of Karnataka, which with a population of 61 million (7.1 
million of which are children 0-6 years of age) is the ninth most populated state. The study 
areas are rural with a predominantly agrarian economy and an average annual household 
income of Indian rupees (INR) 22,006 (US $478), reflecting state and national income 
averages.   
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The study provinces represent the typical religious and sociocultural diversity of rural Indian 
communities. Primary health care to residents of villages in these provinces is provided 
through a network of primary health centers, representative of the Indian rural health system. 
Staff members from these facilities deliver primary health services such as immunization, 
antenatal care, postnatal care, nutritional care and general health advice. Service delivery, 
including iron and folic acid supplements, vitamin A supplements, deworming activities, and 
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patient education, is ensured with logistic support from the National Rural Health Mission 
(NRHM), a program administered by the Ministry of Health, Government of India. The 
center operates under the NRHM program guidelines providing services that are free of cost.  
 
In addition to primary health care, each village in this province is serviced by a network of 
anganwadi day care centers under the administrative support of the Integrated Child 
Development Services (ICDS), a program administered by the Maternal and Child Welfare 
Department, Ministry of Health, Government of India76. The anganwadi day care center is 
usually a simple single room or two roomed facility located in the village, made according to 
guidelines laid by ICDS. The lay health worker in charge of the anganwadi (anganwadi 
worker) is employed by the ICDS and administratively under the supervision of the ICDS 
scheme staff at the district headquarters. The ICDS provide supplementary nutrition, 
preschool non-formal education, nutrition and health education, immunization, health check-
ups and referral services to children, as well as to pregnant and lactating mothers. In theory, 
these services are universal for all categories of beneficiaries and cover all village children 
below 6 years of age, pregnant women and lactating mothers70,76. The anganwadi day care 
center does not participate in primary health care delivery but aims to focus on the nutritional 
health of its beneficiaries.  Therefore, very little coordination of activities happens between 
the primary health care center and the anganwadi day care center. 
 
Health promotion by the primary health care center and the anganwadi day care center is 
supported by a network of non-governmental organizations (NGOs), partially addressing the 
needs of socially disadvantaged communities. These agencies complement efforts by 
providing services in remote areas poorly covered by government. The research team 
partnered with one such non-governmental organization, the Mysore Resettlement and 
Development Agency (MYRADA). Since 1968, MYRADA has worked with more than a 
million families in 18 districts of Karnataka, Andhra Pradesh and Tamil Nadu, improving 
health and education status of the community and building the community’s capacity to raise 
and manage resources independently. The collaborative partnership between an academic 
institute and a local NGO was intended to be mutually beneficial to all stakeholders. A 
history of working with this community over several decades fostered community 
participation.  
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3.3 STUDY PARTICIPANTS 
In study I and II, all healthy rural 12-23 month children living in the study provinces of rural 
Karnataka along with their mothers or caregivers were invited to participate. Invited 
participants were considered eligible if they were living in the village, were in their usual 
state of health, did not have a fever, had not received a blood transfusion in the previous three 
months or had a history of hemoglobin disorder. After obtaining informed consent, subjects 
were recruited between August 2008 and October 2008. 
 
In study III, lay health workers delivering the intervention in the trial were approached to 
complete a questionnaire on anemia awareness after the training. Lay health workers were 
then purposively selected based on the results of this questionnaire (the top 5 best performing 
and the bottom 5 worst performing) and invited to participate in focus group discussions. 
After informed consent, focus group discussions and non-participant observations were 
conducted between October 2014 and April 2015.  
 
In study IV, 60 villages were selected at random from 270 villages in the geographic study 
area and 55 eventually agreed to participate. All caregivers of children aged 12-59 months in 
these villages were invited to participate. Participants were considered eligible if they were 
resident in the village, were in their usual state of health, did not report a fever, and agreed to 
receive counseling and education by the lay health worker upon assignment to the 
intervention group. While obtaining informed consent participants were blinded as to village 
assignment to intervention or control. Participants were recruited between October 2014 and 
July 2015.  
 
3.4 STUDY DESIGN AND INTERVENTION 
 
3.4.1 Anemia determinants and anemia program coverage (Study I & II) 
Studies I and II were cross sectional studies conducted in 12-23 month-old community 
dwelling children and their mothers in two rural provinces of Karnataka state (Figure 9). 
After recruitment and administration of a questionnaire, subjects and their mothers had a 
blood sample obtained by phlebotomy. Questionaires collecting sociodemographic 
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information, 24 Hr dietary intake, food insecurity, and receipt of primary health care services 
including IFA were administered in the local language in the format of an interview 
conducted by a research team member. Anthropometry was performed using standard 
methods. Anticoagulated blood was used to perform a complete blood count, hemoglobin 
electrophoresis, and measure serum Vitamin B12 and Folic acid levels. 
 
3.4.2 Pragmatic cluster randomized controlled trial (Study IV) 
 
3.4.2.1 Study definitions 
 
Cluster was defined as a village in the Chamarajnagar district that was randomly allocated to 
one of the study arms together with the anganwadi day care center or (if the village had more 
than one center) the selected day care center belonging to that village, and its corresponding 
lay health worker. 
Anemia was defined as hemoglobin (Hb) concentration below 11 g/dL. 
Hypoferremia was defined as a serum ferritin concentration below 15 ng/dL. 
Iron deficiency anemia was defined as a hemoglobin  below 11 g/dL and a serum ferritin 
below 15 ng/dL. 
Anemia cure was defined as a child with anemia at baseline whose hemoglobin level at 
follow-up was at or above the threshold of 11 g/dL.  
Net hemoglobin change was measured as the difference in children’s mean hemoglobin level 
between baseline and follow-up. 
Adherence to IFA was defined as the percentage of the total pills consumed divided by the 
total pills dispensed in the previous 30 days obtained during month 6. 
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3.4.2.2 Study protocol 
 
Population 
The target population for enrolment to the trial included all children aged 12-59 months 
registered in the village day care centre. All children and their mothers that were resident in 
the village were potentially eligible. Children were excluded if they had fever (>101°F), 
severe anemia (Hb<8.0g/dL) or had a recent blood transfusion in the previous 3 months. 
Children absent from the village either due to vacation or travelling with parents for religious 
holidays were unable to fulfil eligibility criteria and were excluded. In keeping with the 
guidelines, all non-anemic participants irrespective of treatment group assignment (≥11 g/dL) 
received IFA supplements (8 tablets/month, each containing 20 mg elemental iron) and 
deworming every 6 months (albendazole 400mg, single dose).  
 
Intervention 
1) Lay health workers in the intervention group delivered monthly education and counseling 
only to mothers of anemic children in addition to usual treatment for anemia. These sessions 
were conducted in the participants’ homes and were intended to change: 
• Mothers’ knowledge regarding anemia and its consequences 
• Knowledge of treatment of iron deficiency anemia with IFA   
• Adherence to IFA administration 
• Awareness and use of iron-rich food and enhancers of iron absorption  
• Diet diversification and minimization of dietary iron chelators  
• Hygiene and sanitation 
 
Non-anemic children in intervention villages received the usual prophylactic dose of oral iron 
(reported  in section “Comparator”) 
 
2) Monitoring of adherence to IFA supplements and side effects 
In the intervention group, lay health workers delivering IFA tablets recorded mothers’ 
monthly adherence to the tablets in the previous 30 days for anemic children and 
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recorded side effects to the IFA tablets using a standardized adherence data collection 
form (appendix 4).  
At the end of the trial, during the 6 month follow up visit, adherence to and side 
effects of IFA in the previous 30 days was retrospectively assessed in both the 
intervention and the control groups by the research team using a standardized 
adherence data collection form. 
Training activities also included a module to enhance trial specific documentation skills by 
the intervention group lay health workers enabling measurement of intervention process 
outcomes.  
 
Comparator 
The control group received only received usual care for prevention and treatment of iron 
deficiency anemia according to international consensus statements and in line with National 
guidelines (National Iron Plus Initiative, Appendix 1). Since these guidelines were released 
just prior to trial initiation, specific efforts were made to train the control arm regarding 
changes in the guidelines. In addition, IFA was actively sourced by the research team and 
provided to the lay health worker and monthly telephone contact was maintained to confirm 
IFA delivery. 
• All anemic participants (Hb≥8 and ≤11 gm/dL) received therapeutic IFA 
dosage to control iron deficiency anemia (20 tablets/month, each containing 
20 mg elemental iron for a total period of 5 months) and deworming every 6 
months (albendazole 400mg, single dose).  
 
Outcomes  
Primary outcome 
The primary outcome was anemia cure rate, defined as the proportion of children who were 
diagnosed as anemic at enrollment being no longer anemic at follow up (6 months after the 
start of the intervention). 
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Secondary outcomes 
The trial also assessed several secondary outcomes occurring along the hypothesized causal 
pathway of the interventions effect. These included:  
1) Net change in individual hemoglobin values between baseline and 6 month follow-up 
among anemic children exposed and not exposed to the intervention. 
2) Changes of knowledge and practice of mothers of anemic children from baseline to 6-
months follow-up. 
3) Estimated 24-hour dietary iron intake among anemic participants exposed and not 
exposed to the intervention. 
4) Net improvements in mean ferritin values (indicating iron stores) among anemic 
participants exposed and not exposed to the intervention. 
5) Changes in cluster-level anemia prevalence between baseline and follow up. 
Measures of intervention effects were modeled as outcomes’ ratios or differences between the 
trial groups, as defined further in the statistical methods. 
 
Randomization 
Randomization occurred at the village level. A third party independent of the research team 
performed the randomization prior to enrollment. From a total of 270 villages in 
Chamarajnagar, 60 villages were selected using a computer random number generator127. The 
villages were then stratified based on the number of <6 year-old children listed in the ADC 
registers as being resident in each village. There were 26 villages with <50 children and 34 
villages with ≥50 children. After stratification, the villages were randomly allocated using a 
computer algorithm in a 1:1 ratio to the intervention or control groups, in blocks of 2 in order 
to ensure equal representation of each stratum in both groups. Random assignment was 
subsequently communicated to the lay health workers and after obtaining their informed 
consent, training for the intervention occurred followed by enrolment of children. 
 
3.4.2.3 Lay health worker training 
 
In the intervention group, lay health workers were trained to deliver the intervention in four 
separate hands-on workshops conducted over 6 months. Training techniques included the use 
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of peer group interaction, role-play, facilitation, and group discussions. The training 
workshops were supported with the use of supplementary education material (including flip 
charts provided for each health worker, Appendix 3) with which the lay health workers 
became familiar. Training occurred at a location different from the lay health workers 
habitual training/supervision sites, to minimize the risk of contamination. Each training 
session lasted for one to two days. During each training workshop, the research team 
organized food, accommodation and transportation to and from the training site.  
 
3.4.2.4 Study procedures and field implementation  
 
The trial was implemented in the field by the research team assisted by the village LHW 
during enrollment and trial closure activities. All education and counseling related 
intervention components were delivered solely by the LHW. 
 
Recruitment of participants 
The steps and the flow of recruitment of villages and individual participants are shown in 
Figure 11, in the results section. Participants were mobilized by the anganwadi day care 
center lay health worker. Recruitment occurred at the village anganwadi day care center, and 
lasted usually for 2 days. When <80% of eligible participant were recruited, the research team 
spent an extra day recruiting or returned to the village until 80% of the target population was 
reached. Home visits made on recruitment days helped identify reasons for nonattendance 
and mobilize those that had forgotten to attend. At study entry, a baseline questionnaire and 
other study instruments were used to record participant information and collect relevant data 
(Appendix 4). 
 
Out of 60 randomly selected villages, LHWs agreed to participate in 56 (effects of cluster 
dropout N=4; n=155). Further, random selection of villages with lower numbers of children 
relevant to the study group and an overestimation of children in ADC registry information 
yielded less eligible children (n=1860 vs. 2500). This left 1625 possible children for 
screening. 
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Screening for enrolment of individual children aged 12-59 months and of theirs 
mothers/caregivers was conducted between October 2014 and July 2015. Physical absence of 
families during recruitment (traveling n=341; migrated/untraced n=80) resulted in non-
participation (26%) but the characteristics of non-participants were similar to participants. 
During screening, few individuals either did not consent (n=9). Also in one case 
mothers/caregivers from an entire cluster withdrew consent en masse (N=1; n = 56). Of the 
remaining children screened (n=1219), 75 failed to meet the inclusion criteria and were 
excluded (severe anemia n=50, inability to provide a blood sample n=24 and withdrawal of 
consent during phlebotomy n=1). Lay health worker notified mothers of children with severe 
anemia (Hb<8.0g/dL) of their study ineligibility and referred the child to the primary health 
center for medical care. Thus, from 55 villages a baseline population of 1144 children was 
enrolled to the trial (control villages=27, n=536; intervention villages=28, n=608). 
 
Anemia detection, list of anemic children, and IFA delivery 
All children had venous blood sampled to determine hemoglobin and detect anemia and a 
report of the child’s hemoglobin value was subsequently provided by the research team to the 
lay health worker who then delivered it to the child’s mother. The research team also 
provided lay health workers with a list of anemic and non-anemic children. The research 
team made monthly telephone reminders to lay health workers in both study arms to ensure 
that IFA was delivered to mothers/caregivers.  
 
Intervention delivery and adherence monitoring by the LHW 
In the intervention group, lay health workers delivered the first of five educational and 
counseling sessions (IFA delivery, education and counseling, and adherence monitoring) to 
mothers of anemic children. A month later, during the second session, lay health workers 
delivered the second month’s IFA supply, collected adherence data (obtaining the remaining 
IFA pills/empty strip from the first month) and performed the second education and 
counseling continuing this activity monthly for five months. At the end of the trial, adherence 
and side effects in the previous 30 days was monitored during the end of study visit (6 
months after the start of the intervention) in all study participants in both study arms. 
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Six month follow up visit and end of study  
Approximately 6 months from start of the intervention, all study participants received an end 
of study visit by the research team. At this time the research team obtained venous blood to 
estimate hemoglobin, collected 24-hour dietary recall information, adherence/side effect 
information, and performed anthropometry.  
 
3.4.2.5 Quality control 
Data collection instruments were tested for acceptability in pretrial pilot studies. After trial 
recruitment began, weekly review of recruitment and data collection was performed. All 
questionnaires underwent quality checks on the day of data collection to ensure accuracy and 
address missing values. A quality control manager ensured that data entered in the physical 
case report forms on a day-to-day basis was complete and accurate. Data entry was blinded 
and double entered into an Excel database under the supervision of a dedicated data manager. 
Intervention process outcomes were assessed during monthly checks by the research team for 
completion of the IFA adherence and monitoring forms.  
 
3.4.3 Focus group discussions with lay health workers (Study III) 
 
From 30 lay health workers allocated to the intervention group, 2 declined to participate prior 
to intervention training. Using performance during training as indicative of probably success 
during implementation, we sought to obtain views of both well and less well performing lay 
health workers. To achieve this goal we purposively sampled well performing (n=5) and less 
well performing (n=5) lay health workers based on a questionnaire used to evaluate training 
success. Since nine of the ten LHWs agreed to participate, after the first focus group 
discussion, two additional lay health workers (one well performing and one less well 
performing) were invited to participate (total invited to participate=12). Three focus group 
discussions were conducted in total, the first occurring immediately after intervention training 
and the subsequent two focus group discussions during intervention delivery (Figure 9). All 
focus group discussions were conducted with the same cohort of LHWs in the local language 
by experienced researchers working in the main trial. Focus group discussions were audio 
recorded, transcribed and translated into English using a professional translator, checked for 
accuracy, and then coded independently by two researchers. 
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In addition to the focus group discussions, we gained broader insights into implementation 
with non-participant observations and maintenance of detailed field notes. For non-participant 
observations, the research team based on their field experience purposively sampled two lay 
health workers that implemented the intervention easily and two that encountered difficulties 
implementing the intervention. Observations were conducted over multiple time points 
during intervention conduct. Detailed field notes were maintained by the research team 
during conduct of the intervention training,  focus group discussions and the nonparticipant 
observations and were subsequently used to validate emerging themes from the focus group 
discussions. Data triangulation using multiple data sources was sought to enhance validity. 
 
3.5 LABORATORY METHODS 
 
3.5.1 Sample processing, storage and transport  
All blood samples were collected and processed in the Chamarajnagar field 
laboratory within 6 hours of blood collection. Anticoagulated blood was used 
immediately to obtain complete blood counts, and then processed appropriately to 
obtain serum and plasma. Samples for ferritin assays were stored at -20C in the 
field laboratory and transported weekly on dry ice to the hematology research 
laboratory at St. Johns National Academy of Health Sciences where they were 
stored at -80C for batch analysis at a later date.  
 
3.5.2 Complete blood counts  
A complete blood count was measured using a three-part differential automated 
cell counter (Sysmex XP 300, Transasia Laboratories, Tokyo, Japan) located in 
the field laboratory at the Chamarajnagar district.  
 
3.5.3 Iron stores 
 
Ferritin was measured using an immunoassay detected by chemiluminescence 
(Access 2, Beckman Coulter, California, USA).  
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3.5.4 Quality control for laboratory 
Trained laboratory personnel using standard operating protocols following 
principles of Good Laboratory Practice performed all tests described above. 
Research staff maintained daily quality control checks of the field automated cell 
counter instrument to ensure accurate hemoglobin measurements and verified 
these weekly in the Hematology Research Laboratory at St. Johns National 
Academy of Health Sciences. The sample processing, storage and assay 
conditions were field tested in pilot studies to confirmed that preanalytical 
variables did not affect hemoglobin and ferritin measurements. A bar coded 
sample management software ensured that samples were accurately labeled prior 
to storage to minimize errors during future batch analysis. 
 
 
3.6 STATISTICAL METHODS 
 
3.6.1 Study I and II 
Linear and logistic regression analysis was performed to assess the cross-sectional 
associations between socio-demographic and behavioral characteristics of participants and 
hemoglobin (continuous variable) or receipt of iron supplementation (binary variable). The fit 
of each model was evaluated with likelihood ratio testing and confirmed using either the 
Shapiro-Wilk test or Hosmer-Lemeshow goodness-of-fit test.  
 
3.6.2 Study III 
 
The analysis of focus group discussions centered on lay health worker perceptions, 
acceptability and experiences with regard to the intervention particularly attempting to 
identify barriers and facilitators to its implementation. The data corpus was analyzed 
inductively using the framework method to ensure systematic analysis of themes identified 
across all the different sources of transcripts128,129. Analysis was conducted independently by 
two members of the research team. Each transcript was manually coded, and from these 
codes, abstractions were developed to form categories, followed by themes. Subsequently, a 
framework of these themes was developed, following which the transcripts were re-coded 
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into the framework. Non-participant observations and field notes were similarly manually 
coded and analyzed inductively. 
  
3.6.3 Study IV 
 
Sample size estimation 
A 12% difference in 6-month anemia cure rates after 6 months was judged to be clinically 
meaningful, based on published trials of anemia treatment 96,130. To detect this difference at 
an alpha level of 0.05 for a two-tailed test, with 80% power, a total unadjusted sample size of 
500 children with anemia was required. After adjustment for clustering (design effect = 2.2; 
intracluster correlation coefficient (ICC) = 0.05 and cluster size = 25),  a total sample size of 
1,100 children with anemia was estimated. Allowing for a 10% loss to follow-up of children 
identified with anemia at baseline, led to a final sample size of 610 children with anemia per 
arm (1,220 in all)131. Assuming a 50% anemia prevalence20, it was calculated that screening 
of 1,220 in each arm (total = 2440) would be required to achieve this desired sample.  
Statistical analysis 
The intervention’s effect was expressed as Risk Ratio (RR) with the corresponding 95% 
Confidence Interval (CI) of being non-anemic at follow-up in the intervention group relative 
to usual treatment. The estimate of effects was derived through multilevel models based on 
Poisson distribution. We used linear regression to study the interventions effect concerning 
the secondary outcome, net hemoglobin change.  
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4 RESULTS 
 
4.1 STUDY I: PRETRIAL ANEMIA ETIOLOGY AND DETERMINANTS  
 
There were 405 children and corresponding 364 consenting mothers participating in the study 
and providing a venous blood sample. The mean age of children was 17.2 months, and 204 
(50.3%) were boys.  
Social and demographic characteristics 
The mean age of mothers in the study was 23 years with a 70% literacy rate and a median of 
7 years of schooling. The socioeconomic status determined by the demographic and health 
survey wealth index yielded a mean score of 18 (SD1.2), similar to other national rural 
Indian populations estimated in the NFHS 3 survey.  
 
Anemia prevalence and determinants 
Anemia prevalence in children was high (75%). Iron deficiency anemia, defined as anemia 
(Hb<11g/dL) in the presence of either a ferritin of <15ng/dl or a ferritin of <30ng/dl when the 
CRP was >5mg/L, accounted for the majority of cases (62%). Children with anemia were 
more likely to have iron deficiency (OR 6.1; p <0.001) and a mother herself having anemia 
(OR 1.9; p <0.01) compared to children without anemia 
Multiple regression analysis performed using children’s hemoglobin as a continuous variable 
identified hemoglobin to be primarily associated with serum ferritin (an indicator of body 
iron stores) but also positively associated with maternal hemoglobin level, folate intake, the 
child’s age, family wealth and food security. Children’s hemoglobin was inversely associated 
with male gender, CRP levels, and the presence of thalassemia trait. 
 
 
 
 
 
KEY FINDINGS (STUDY I) 
• The prevalence of anemia was high among Indian children (75%) and the majority of 
anemia was due to iron deficiency (62%).  
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4.2 STUDY II: COVERAGE OF CHILDREN BY THE NATIONAL ANEMIA 
CONTROL PROGRAM 
 
Study II was conducted contemporaneously with Study I and had the same source population. 
Eventually 403 children and 376 mothers were included in the analysis. 
 
Coverage of children with IFA by national program 
Less than half of the mothers (42%) reported receipt of IFA for their child in the preceding 12 
months of the study and only a minority of those (30%) reported that the IFA they provided 
their child was obtained from the national anemia control program. Most mothers (70%) 
reported purchasing iron directly from a private pharmacy through a prescription obtained 
from a private physician. Primary health care service coverage i.e., antenatal and postnatal 
visits; receipt of vaccinations and immunization; Vitamin A supplements; and visits to the 
primary health center and anganwadi day care center was above 90%.  
 
Factors associated with IFA coverage for children 
Factors associated with greater odds of a child having received IFA included being male, 
belonging to a higher socioeconomic background, having a mother tested for anemia during 
pregnancy, and having a mother receiving IFA during pregnancy. Factors were associated 
with lower odds of a child receiving IFA tablets were: the mother’s religion being identified 
as Muslim, and the child having received good primary care (being fully vaccinated, 
previously visiting the anganwadi day care center or having a mother that required more 
antenatal health worker visits). 
 
 
 
 
 
KEY FINDINGS (STUDY II) 
• The coverage of beneficiaries (children) with IFA was low with less than half (42%) 
of mother admitting to giving IFA to their child in the previous 12 months. 
 
•  Among those children receiving IFA, approximately one third (30%) were covered 
with IFA provided by the government national anemia control program. The rest 
(70%) received IFA purchased from private pharmaceutical stores.  
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4.3 STUDY III: LAY HEALTH WORKER PERCEPTIONS OF THE ANEMIA 
INTERVENTION 
 
In this qualitative study, 10 out of a possible 28 lay health workers participating  in the 
intervention were initially selected purposively to conduct focus group discussions and non-
participant observations immediately after training for the intervention and during 
intervention delivery. Nine of the ten LHWs agreed to participate. Subsequently, one of the 
nine LHWs was unable to continue participating in the remaining focus group discussions 
resulting in the inclusion of two additional LHWs (one well performing and one less well 
performing). Thus, eleven lay health workers eventually participated. 
 
Overall feasibility of the intervention 
Analysis of the lay health worker focus group discussions using the framework method 
identified the following themes (Table 4): i) initial acceptance of the intervention changing 
over time; ii) ability to innovate and adapt the implementation protocol; iii) precarious 
relationships with mothers in participating communities; and iv) working conditions 
challenging intervention delivery. 
Non-participant observations and field notes supported themes identified in the focus group 
discussions and provided  explanations as to why supplementary educational materials were 
not used by the lay health worker during implementation. Some lay health workers explained 
this behaviour with the feeling that they had a good grasp of the materials and did not require 
prompts during intervention delivery. 
Overall, lay health workers found the intervention feasible to deliver during routine activities, 
and appeared genuinely pleased to participate in a trial to improve children’s health. 
Modifiable barriers to the successful implementation of this intervention were seen at two 
levels. At a broader contextual level, hindering factors included being overburdened, 
inadequately reimbursed, and receiving insufficient employer support. At the health system 
level, lack of streamlining of duties, inability to diagnose anemia in the village and temporary 
shortfalls in the availability of iron supplements were barriers.  
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Theme #  
1. Lay health workers initial acceptance of the intervention changing over time 
• Intervention found feasible to deliver during routine activities 
• Pleasure in trial participation, optimism, need to continue after trial completion 
• Waning of enthusiasm while performing activities 
• Forms burdensome, work not feasible long term, lack of health system support 
 
2. Lay health workers innovating and adapting the implementation protocol 
• Incorporating intervention activities in daily schedule 
• Delivering intervention at day care center 
• Inconsistent use of supplementary educational material 
 
3. Lay health workers having a precarious relationships with mothers in 
participating communities 
• Multiple roles complicating the relationship 
• Status in the community positively influencing the relationship 
4. Lay health workers working conditions challenging intervention delivery 
• Wide ranging services and high burden of work 
• Salary concerns 
• Job security concerns 
• Inadequate employer support and recognition 
 
KEY FINDINGS (STUDY III) 
• Results from qualitative study showed that the intervention was acceptable to lay 
health workers who found it easy to incorporate in their usual activities. 
 
• Lay health worker workload, burdensome working conditions, and low job 
satisfaction were several important barriers to optimal implementation.  
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4.4 STUDY IV: INTERVENTIONS EFFECTS ON ANEMIA CURE RATE 
In the recruited population, 534 children (43%; n=231 in the usual treatment group and 50%; 
n=303 in the intervention group) were anemic, constituting the comparison groups for the 
primary outcome of the intervention (Figure 11). At the end of six-month follow-up, 517 of 
these children were again assessed (usual treatment=219 and intervention=298).  
LFU, loss to follow up 
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Characteristics of participants at baseline 
 
No significant between-group differences in mean age, sex, maternal age, parity, breast-
feeding patterns, 24-hour dietary iron intake and standard of living were apparent in the 
baseline population. However, modest between-group differences at baseline were detected in 
mean hemoglobin, mother/caregiver’s education level and child’s birth weight. The high 
overall prevalence of indicators of acute and chronic malnutrition suggested overall poor 
childhood nutritional status. Dietary iron intake was less than 50% of the recommended daily 
iron allowance and probably contributed to the low total body iron stores. Thus, non-anemic 
children had a high prevalence of nutritional iron deficiency (Hb>11g/dL and serum ferritin 
of <15ng/ml) and iron deficiency anemia (Hb<11g/dL combined with ferritin <15ng/ml) was 
detected in over 80% of the anemic children.  
 
Anemia cure rate, net hemoglobin change and IFA adherence 
In an intention-to-treat (ITT) analysis, anemia cure rate at the end of 6-month treatment 
follow-up was significantly higher in the intervention group compared with the usual 
treatment group (55.7%, 95% CI 50-61.3 vs. 41.1%, 95% CI 34.5-47.6) resulting in a 14.5% 
difference that was larger than the preplanned minimally important clinical difference of 
12%. After taking clustering into account, the risk ratio of anemia cure for intervention vs. 
control was 1.33 (1.04-1.69). The analysis of Hb change between baseline and follow up 
among anemic children revealed a mean increase of 1.08, SD=0.10 g/dL in the intervention 
group and of 0.83, SD=0.11 g/dL in the usual treatment group, i.e. a between-group mean 
difference of 0.26 g/dL (95% CI 0.07-0.44; p=0.006). In a linear mixed effects model 
analysis adjusted for clustering, the mean hemoglobin difference was 0.24 g/dL. During study 
month six, anemic children in the intervention group consumed significantly more IFA 
tablets than anemic children in the usual treatment group (proportion of children with >75% 
adherence to IFA tablets, 61.7% vs. 48.4%).  
 
KEY FINDINGS (STUDY IV) 
• Anemic children exposed to the intervention were 1.33 times more likely to have their 
anemia cured and also had a higher mean hemoglobin difference from baseline to the 6 
month follow up point. 
 
• Anemic children exposed to the intervention also consumed more IFA tablets, 
strengthening the conclusion that anemia cure was related to better treatment adherence. 
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5 DISCUSSION 
 
The studies included in this thesis demonstrated both high prevalence of childhood iron 
deficiency anemia and inadequate coverage of children by the national anemia control 
program in this district of Karnataka, South India. Based on this information a novel 
intervention was designed, as education and counseling specifically targeting anemic 
children’s caregivers, thereby strengthening community-based anemia control. We evaluated 
the outcome and the potential population impact of this intervention using both qualitative 
and quantitative studies. In a pragmatic cluster randomized trial we estimated the 
effectiveness of this intervention when combined with usual anemia treatment, while the 
perspectives of lay health workers delivering the counseling were analyzed in a qualitative 
study using focus group interviews. This approach allowed the identification of individual 
and health system barriers to effective implementation.  
Children exposed to the intervention were more likely to have their anemia cured compared 
with children exposed to usual treatment. Moreover, children exposed to the intervention 
achieved a higher net hemoglobin increase (equivalent to a quarter unit blood transfusion) 
compared to children exposed to usual treatment. These differences were consistent with 
greater adherence to medicinal iron in anemic children exposed to the intervention compared 
with anemic children exposed to usual treatment thus strengthening the plausibility of a 
causal effect. The advantages of the intervention were seemingly achieved through 
reasonable costs, as seven mothers/caregivers needed to be educated/counseled in order to 
cure one anemic child (NNT=7). The results can be used by state and national policy makers 
to make public health decisions regarding childhood anemia control based upon scientific 
evidence. 
 
5.1 NEW ESTIMATES OF THE PREVALENCE AND DETERMINANTS OF 
CHILDHOOD ANEMIA IN RURAL AREAS 
 
Compared with previous studies in this region, we used more accurate methods to estimate 
plasma hemoglobin (automated hemocytometry using the coulter principle) thus providing 
credible childhood anemia prevalence estimates in this province. The study also revealed a 
low prevalence of folate, B12, Vitamin A, worm infestation, thalassemia, and malaria) in 
healthy rural Indian children contrary to a small study in urban children17. Two recent studies 
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in children under age five from rural north and south India confirm this high iron deficiency 
anemia prevalence19,21. Thalassemia, sickle cell anemia and malaria infections are rare in this 
province20 suggesting that population wide iron supplementation programs might be 
expanded without much risk for toxicity from IFA132 or iron overload.  
 
5.2 IRON AND FOLIC ACID COVERAGE OF CHILDREN BY THE NATIONAL 
ANEMIA CONTROL PROGRAM 
 
In population-wide anemia control efforts, it is of paramount importance to assess the extent 
of the program’s coverage regarding the intended target population. Despite this well-
acknowledged need, prior studies did not assess whether children’s caregivers had previously 
ever received iron supplements for their children. Instead, they asked whether 
mothers/caregivers were actively receiving IFA. Due to this methodological difference, 
coverage of beneficiaries from our study (41%) and data from a national survey (3%) are not 
directly comparable28,133. More recent data from a demographic survey in the north Indian 
state of Bihar yielded coverage estimates similar to ours (46%)111, providing confirmation 
that the national iron supplementation program coverage remains suboptimal. Most mothers 
(70%) paid out of pocket for IFA prescribed by a health provider, possibly due to 
combination of lack of awareness and/or insufficiency of IFA due to an overburdened health 
system75,134, emphasizing the importance of publicizing government led anemia control 
efforts in rural communities135.  
 
Our seemingly paradoxical observation that an anganwadi day care center visit by 
mothers/caregivers was associated with significantly lower IFA receipt is not easily 
explained133. A possible explanation for this discrepancy could be that the study population 
consisted only of 12-23 month old children that unlike 36-59 month old children are not 
targets of the ICDS program136.  
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5.3 THE NOVEL APPROACH CONVEYED BY THE COMMUNITY-BASED 
INTERVENTION  
 
The intervention evaluated in the frame of this research project was developed using the 
combined strengths of several disciplines including pediatrics, community health, nutrition, 
social science, hematology, biochemistry, epidemiology and biostatistics. Evaluating 
interventions in logistically challenging health systems is facilitated by mixed method 
approaches90,137,138 with qualitative studies often providing explanations about 
implementation processes, mechanisms, and sometimes explaining trial results126. Moreover, 
targeting the intervention to mothers/caregivers of anemic children and facilitating its uptake 
by the anganwadi lay health worker overcame any potential encumbrances that may have 
limited the positive behavioral effects of this community intervention90,139,140. Specific 
contextual challenges discussed further below included: i) recruitment of participants, ii) 
procuring uninterrupted government issued iron supplements and iii) human resource 
challenges that challenged smooth intervention implementation. 
i) Recruitment and participation: Although specific efforts were made to maximize 
participation, due to unavoidable reasons (travel away from the village) some 
mothers/caregivers were non-contactable. Among those that mothers/caregivers were 
contacted and screened, refusal rates were very low. 
ii) IFA supply and procurement: Consistent with published data134, our field experiences 
revealed interruptions to the state government procured IFA supply. When these occurred, the 
research team worked closely with state government officials to source IFA and avoided 
major implementation delays.  
iii) Human resource challenges: A three-week strike by lay health workers mid-way through 
the study delayed trial implementation. Qualitative studies provided important insights into 
factors motivating community health worker performance and permitted a deeper 
understanding of the lay health worker condition141-144. Therefore, additional qualitative 
research of lay health worker led community-based interventions is required145.  
 
5.4 COMMUNITY-BASED INTERVENTIONS FOR ANEMIA 
Large-scale community-based interventions with investment in community health workers 
have yielded impressive gains in maternal and childhood mortality in Bangladesh29,97. 
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Moreover, the opportunity to deliver health-services with maximal reach is optimized by 
informal and contractual partnerships that capitalize on the ability of non-governmental 
organizations to generate community trust, and reach the most deprived populations to 
address service gaps97. Our experience in India supports this literature, reinforcing the notion 
that rigorous scientific experiments in resource-limited setting are feasible and yield 
important contextual information.  
 
Community-based nutrition interventions, iron supplementation uptake, and adherence to iron 
have previously been shown to be enhanced by i) education and counseling, ii) provision of 
free medicinal iron, iii) directly observed therapy, iv) education seeking to promote behavior 
change, v) parental involvement, and vi) use of community facilitators66-70,80,96,146-151. 
Community-based education as a childhood anemia prevention strategy has been evaluated 
using less rigorous methods than experimental studies80,148,149. In addition, these studies did 
not include anemic children and did not specifically assess anemia cure rate as the primary 
endpoint. In the current trial, we evaluated for the very first time, the combined effects of lay 
health worker delivered mother/caregiver education combined with medicinal iron on 
children’s anemia cure rate. We found that this intervention enhanced the effectiveness of the 
medicinal iron treatment, probably because of improved adherence. The simple and scalable 
nature of this intervention combined with its feasibility and acceptance by lay health workers 
imply that wider implementation could improve childhood anemia control.  
 
The trial provides scientific evidence for the tangible benefits of mother/caregiver education 
and counseling in improving the effectiveness of prescribed iron for the treatment of anemia 
in children. Moreover, education and general awareness of anemia in the community matter 
to bringing about behavior change152. However, to further optimize such community-based 
anemia interventions, sociocultural and behavioral factors must be also considered153. On the 
one hand, anemia must be seen as an important health problem by people in the community. 
On the other hand, lay health workers must feel that the intervention they deliver is in line 
with their training and contributes positively to their performance as judged by their 
superiors, by the clients and by the whole community112,141,152. Several models of community-
based interventions exist depending on the setting of the intervention, its target for health 
promotion, and its involvement of the community as an agent or resource154. Harnessing the 
community as an agent to strengthen its own health and building its capacity to address 
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health-related issues would better prepare mothers/caregivers to receive anemia treatment 
measures and optimize intervention success.   
 
5.5 METHODOLOGICAL CONSIDERATIONS 
 
5.5.1 Study limitations  
 
Cross sectional study design 
The studies evaluating anemia prevalence and receipt of iron supplements were cross 
sectional and therefore precluded conclusions about the direction of associations. The 
prevalence study also incompletely phenotyped anemia in 10% of the children with 
biochemical evidence of inflammation due to the inability to test for sTfR21 or serum 
hepcidin4.  
 
Qualitative study 
Qualitative studies conducted alongside randomized controlled trials may generate responses 
atypical of individuals that are unlikely to participate. Additionally, the number of focus 
group discussions in this study was small limiting transferability. Other important 
considerations in this setting are the hierarchical structure of health care in India and subtle  
power equations that may have unduly influenced lay health workers responses. Finally, the 
study was limited by the absence of focus group discussions with mothers/caregivers that 
may have provided a holistic perspective of the intervention. 
 
Non-participation 
Although considered a gold standard for evaluation of effectiveness because of their inherent 
control for known and unknown sources of confounding, randomized experiments are prone 
to selection bias with post-randomization events representing the major threats to 
validity155,156. In cluster randomized experiments this can happen at both the cluster and the 
individual levels. 
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Cluster level: After randomization, four lay health workers (2 from each group) elected not to 
participate in the trial. Additionally, while screening the baseline population, 
mothers/caregivers in one village withdrew consent en masse. However, no clusters were lost 
to follow up after enrolment of the baseline population. It may be hypothesized that these 
exclusions occurred amongst less motivated lay health workers/mothers with validity 
consequences and possible implications during wider implementation of the intervention.  
 
Individual level: Despite efforts to maximize participation, some children and their 
mothers/caregivers could not participate because they were traveling raising some concerns 
regarding validity. Thus, it was reassuring to learn that the baseline characteristics available 
from these missing, not contactable and non-consenting participants were similar to those of 
participants (Appendix 5). Unfortunately, access to blood samples and consequently 
hemoglobin values leaves the anemia status of these children unknown.  
 
Potential for contamination 
Lay health worker training was conducted at a location distinct from the administrative 
headquarters to minimize the risk of contamination. Moreover, the geographic distance 
between villages precluded travel between intervention and control villages further limiting 
contamination. Even when lay health workers in the control group became aware of the 
intervention, they neither received training to deliver the intervention nor had access to 
training materials, factors severely limiting their ability to successfully deliver the 
intervention in control villages. Thus, misclassification of exposure due to contamination 
would be quite unlikely, and would in any case rather attenuate the estimate of effect, i.e. the 
anemia cure rate ratio and difference. 
 
Effects of attrition  
Individuals: Individual attrition among  anemic children was extremely low (n=17; 3%), 
relatively balanced among the treatment groups and occurred for a variety of known reasons. 
In the control group (n=12) loss to follow up was due to migration (n=5), withdrawal of 
consent (n=4), failure to obtain blood during phlebotomy (n=3). In the intervention group 
(n=5) loss to follow up was lower occurring for similar reasons: migration (n=2), withdrawal 
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of consent (n=1) and failure to obtain blood during phlebotomy (n=2). Thus, efficient follow 
up of clusters and individuals in the study minimized attrition. 
 
Sample size and power considerations 
In cluster randomized trials, the total number of clusters affect power more than the total 
number of individuals within a cluster157. Post-randomization cluster attrition was very small 
and occurred prior to enrolment of the baseline population. Moreover, the eventual number of 
participating clusters (intervention=28 and control=27) was greater than the a priori minimum 
required per treatment group (cluster number=25/arm). Cluster loss therefore minimally 
impacted study power. 
 
More importantly, the trial fell short of individual anemic subject recruitment by 50%, raising 
concerns of a threat to internal validity from a type II error. However, any reduction in power 
was counterbalanced by  the larger than anticipated effect size (15%), the lower than expected 
standard deviation of mean hemoglobin values (0.68 vs. 1.2) and the lower than anticipated 
number of subjects lost to follow up158.  
 
The intraclass cluster correlation coefficient (ICC) results from the correlation between 
responses of individuals in the same cluster, providing an estimate of  the proportion of the 
total variance explained by between clusters variance. Clustering accounted for 18% of the 
variability in anemia cure rate at the village level (ICC=0.18). However, the effect of 
clustering on net change in hemoglobin between baseline and follow up among anemic 
children in both treatment groups was less pronounced accounting for less than 9% of the 
variability in hemoglobin change (ICC=0.086). 
 
High level of usual care 
The control group received usual treatment at a level higher than usual. This was due to 
factors associated with trial participation such as training of the lay health workers, repeated 
blood testing of participants, and sharing of hemoglobin results i.e., trial activities themselves 
that may have prompted practice changes among lay health workers. Of note, anemia cure 
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rates of 41% in the usual treatment arm were similar to those observed in a previously 
published individual randomized controlled trial conducted in a contextually similar 
setting159. It is therefore possible that in a non-experimental setting with lower lay health 
worker and mother/caregiver awareness, the interventions’ effect size would be larger. 
 
5.5.2 Study strengths 
 
Internal validity 
The validity or trustworthiness of the qualitative study was enhanced by ensuring two 
independent data analysts as well as the use of data triangulation. 
 
The intervention trial was conducted with methodological rigor and sought to ensure a high 
degree of internal validity by random selection of villages, random allocation to the 
intervention and blinded assessments of outcome. Over 80% of the “anemic cases” had iron 
deficiency anemia using rigorous criteria for case definition. Objective and reliable  outcome 
measures such as hemoglobin, serum ferritin, pill count adherence and dietary iron intake 
measures also contributed towards maintaining internal validity. The definition of anemia 
cure rate (return of Hb to its normal value at or above 11g/dL) ensured clinical relevance to 
practitioners. Finally, the baseline characteristics between participants and non-participants 
were similar, providing reassurance of the success of randomization. In a sensitivity analysis, 
considering all children lost to follow-up as not having changed their anemic status (worst 
case scenario), the corresponding proportions were 54.8 and 39% in the intervention and 
usual treatment groups, respectively. Additional sensitivity analyses demonstrated that minor 
baseline imbalances in hemoglobin and maternal education that were most likely due to 
chance did not exert any confounding effect on the estimates. 
 
External validity 
Based on the pragmatic design and the setting in which this intervention was conducted, the 
cluster randomized trial results may be widely generalizable to anemic individuals (both 
adults and children) living in similar agrarian parts of India and possibly to other similar 
agrarian regions of the world. 
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5.6 ETHICAL CONSIDERATIONS 
 
The studies were performed according to Good Clinical Practice Guidelines and the 
principles of Declaration of Helsinki and appropriate ethical approvals were obtained from 
the institutional ethical review board prior to study initiation. In addition the trial was 
registered with ISCRTN. An independent Data and Safety Monitoring Board (DSMB), 
including a statistician, pediatrician and an internist with clinical trials expertise, reviewed the 
data and performed a pre-specified blinded interim analysis mid-way thought the trial. 
 
Written Informed Consent and Confidentiality 
Participants in all the studies in this thesis provided written informed consent and 
confidentiality was maintained throughout the study by the use of a unique participant 
identification number on questionnaires, case report forms, laboratory results, stored samples, 
or in the database. Similar efforts to maintain the confidentiality of lay health workers 
participating in the focus group discussions were taken. 
 
Cluster randomization 
Cluster randomization at the level of the village minimized ethical concerns about the 
decision to allocate individual participants from the same village to different regimens. This 
strategy offered greater administrative flexibility during field implementation and provided 
lay health workers with greater parental credibility during study recruitment. 
 
Involvement of the community and its health infrastructure 
The community was actively involved in the design and implementation of the intervention 
with consultation of elders and use of community health workers from the local village for 
intervention delivery. The existing health infrastructure was utilized for referral and medical 
management of ineligible children with severe anemia. Active involvement of local 
government officials and the use of locally sourced IFA provide contextually relevant 
information to stakeholders and policy makers. 
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Promoting equity 
As a direct benefit of this intervention, improving children’s health and nutrition promoted 
equity in two ways. First, the poorest children, the ones benefiting most from health and 
nutrition programs, harbor the greatest burden of disease. Second, amongst those susceptible 
to poor health and nutrition, treating disease confers the greatest benefit on the most 
vulnerable children: on the poorest and on those suffering from other micronutrient 
deficiency related disease.  
 
Cost effectiveness 
Although the interventions’ cost-effectiveness has not been formally assessed, nutrition 
education interventions are considerably low cost99, making this a key priority for the Indian 
government. In conditions such as iron deficiency anemia that can be treated with a few pills, 
such as with iron and deworming, costs are typically lower than $5 per child per year.  
 
Sustainability  
The study team in collaboration with the NGO partner disseminated results of anemia 
prevalence rates and obtained feedback from lay health workers participating in the 
intervention. Several Karnataka state level officers from the district attended this meeting. 
Future dissemination workshops with stakeholders, academicians, researchers, public health 
nutritionists, social scientists, pediatricians, state and national government actors and policy 
makers are warranted. 
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WHAT DO THE STUDIES IN THIS THESIS ADD TO THE LITERATURE? 
 
i) The prevalence of iron deficiency anemia was documented for the first time 
using valid biomarkers of iron status in a large sample of community dwelling 
rural toddlers from south India. Furthermore, the reach of anemia control 
activities to young children was clearly defined. 
 
ii) Design and implementation of community-based education interventions 
demonstrated high  feasibility. This points toward a great advantage of local 
practitioners delivering community based interventions, both in terms of 
performance and in terms of recognition of their roles 
 
iii) Community-based experimental studies can be conducted with high 
methodologic standards even in a logistically challenging environment. 
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6 CONCLUSIONS 
 
• Childhood iron deficiency anemia was highly prevalent in this district of Karnataka in 
rural South India.  
 
• Coverage of children with iron supplements from the national anemia control 
program was suboptimal. Rather than obtain medicinal iron free of cost from the 
national program, over half the mothers in this study paid out of pocket to purchase 
medicinal iron from a private pharmacy. 
 
• The development of a community-based intervention was facilitated by 
interdisciplinary collaboration, community engagement, involvement of field research 
agencies, and local government stakeholders. 
 
• A pragmatic experiment provided scientific evidence that mother/caregiver 
education/counselling enhances the effects of nutritional programs based on iron 
supplements alone and adds to population level anemia control activities.  
 
 
• Qualitative studies conducted alongside randomized trials in rural communities 
identified barriers and facilitators to trial implementation and provided insights on 
how to optimize intervention uptake.  
 
 
• Performing rigorous scientific experiments in rural communities is feasible and 
provides an important evidence base to guide policy makers. 
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7 POLICY IMPLICATIONS 
 
7.1 RESEARCH PRACTICE AND POLICY IMPLICATIONS 
 
Childhood iron deficiency anemia is a major concern in this rural district and other similar 
rural agrarian parts of India.  Overall, these studies suggest that childhood iron deficiency 
anemia should be prioritized in the Indian context. The National Iron Plus Initiative has made 
important modifications to anemia control policy in India yet several important issues remain 
unaddressed. Specifically, clear government issued directives for implementation and routine 
monitoring/evaluation procedures are required. Moreover, the guidelines must indicate how 
anemia control programs should screen, detect and treat anemic children.  
 
The studies in this thesis clearly demonstrate the effectiveness of a public health intervention 
when used to specifically target anemic children. The pragmatic design of the study ensures 
that the resultant information is of direct relevance to support Indian policy makers when 
making choices regarding population anemia control in India. 
 
Implementing this intervention in other geographic areas of high IDA prevalence may reduce 
the global burden of childhood anemia prevalence. However, additional studies are required 
to determine whether these findings are replicable in India and perhaps other low middle-
income countries. Specifically, these include optimal screening to detect anemic children by 
lay health workers and methods to enhance training uptake by lay health workers from 
different regions of the country. 
 
From a broader perspective, several factors apart from nutritional iron deficiency contribute 
to anemia prevalence. Characterizing the contribution of infectious diseases, functional iron 
deficiency and genetic factors to the overall burden of anemia would inform the design of 
future community-based interventions. 
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10 APPENDICES 
Guidelines for Control of
Iron Deficiency Anaemia
$33(1',;

17
6XSSOHPHQWDWLRQWKURXJKWKH 
/LIH&\FOH
$Q DQDHPLD VXSSOHPHQWDWLRQ SURJUDPPH DFURVV WKH OLIH F\FOH LV SURSRVHG LQ ZKLFK 
EHQH¿FLDULHV ZLOO UHFHLYH LURQ DQG IROLF DFLG VXSSOHPHQWDWLRQ LUUHVSHFWLYH RI WKHLU LURQ+E
VWDWXV7KH DJHVSHFL¿F LQWHUYHQWLRQV DUH EDVHG RQ :+2 UHFRPPHQGDWLRQV V\QWKHVLV
RI JOREDO HYLGHQFH RQ ,)$ VXSSOHPHQWDWLRQ DQG WKH UHFRPPHQGDWLRQV RI QDWLRQDO H[SHUWV 
7DEOHDQG)LJXUH
Table 6.1: IFA supplementation programme and service delivery
Age group Intervention/Dose Regime Service delivery
±PRQWKV 1ml of IFA syrup 
FRQWDLQLQJPJRI
elemental iron and  
PFJRIIROLFDFLG
%LZHHNO\WKURXJKRXW
WKHSHULRG±
PRQWKVRIDJHDQG 
GHZRUPLQJIRU
children 12 months 
DQGDERYH
7KURXJK$6+$
Inclusion in MCP card
±\HDUV 7DEOHWVRIPJ
elemental iron and  
PFJRIIROLFDFLG
:HHNO\WKURXJKRXWWKH
SHULRG±\HDUVRI
DJHDQGELDQQXDO 
GHZRUPLQJ
,QVFKRROWKURXJK
teachers and for out-of-
VFKRROFKLOGUHQWKURXJK
$QJDQZDGLFHQWUH$:&
0RELOL]DWLRQE\$6+$
±\HDUV PJHOHPHQWDOLURQ
DQGPFJRIIROLF
acid
:HHNO\WKURXJKRXWWKH
SHULRG±\HDUVRI
DJHDQGELDQQXDO 
GHZRUPLQJ
,QVFKRROWKURXJKWHDFKHUV
and for those out-of-school 
WKURXJK$:&
0RELOL]DWLRQE\$6+$
3UHJQDQWDQGODFWDWLQJ
ZRPHQ
PJHOHPHQWDOLURQ
DQGPFJRI 
folic acid
WDEOHWGDLO\IRU
GD\VVWDUWLQJDIWHUWKH
¿UVWWULPHVWHUDW 
±ZHHNVRI
JHVWDWLRQ7REH
UHSHDWHGIRUGD\V
post-partum. 
ANC/ ANM /ASHA 
Inclusion in MCP card
Women in reproductive 
DJH:5$JURXS
PJHOHPHQWDOLURQ
DQGPFJRI 
folic acid
:HHNO\WKURXJKRXWWKH
reproductive period 
7KURXJK$6+$
GXULQJKRXVHYLVLWIRU
FRQWUDFHSWLYHGLVWULEXWLRQ
$6+$WREHVXLWDEO\LQFHQWLYL]HGIRUSURYLVLRQ,)$VXSSOHPHQWVWREHQH¿FLDU\
Note:7KH,)$VXSSOHPHQWDWLRQSURJUDPPHLVDSUHYHQWLYHSXEOLFKHDOWKPHDVXUHDQGVKRXOGQRWEH
FRQIXVHGZLWKWUHDWPHQWRI,'$ZKLFKLVGHDOWZLWKLQWKHVXEVHTXHQWVHFWLRQ
6
*XLGHOLQHVIRU&RQWURORI,URQ'H¿FLHQF\$QDHPLD
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Fig. 6.1: IFA supplementation programme
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CHILDREN 
PREGNANT
AND LACTATING 
WOMEN 
ADOLESCENTS
WOMEN OF 
REPRODUCTIVE 
AGE
2YHUYLHZRI,PSOHPHQWDWLRQ0RGDOLWLHVIRU 
,)$6XSSOHPHQWDWLRQIRU(DFK7DUJHW6HJPHQW
6XSSOHPHQWDWLRQIRU&KLOGUHQ±PRQWKV
7KHRQVHWRIDQDHPLDLQ\RXQJFKLOGUHQLVJHQHUDOO\DIWHUPRQWKVRIDJH%HIRUHWKLVLURQ
LQEUHDVWPLON LVVXI¿FLHQW WRPHHW WKHQHHGVRIDEUHDVWIHGFKLOG ,URQ IURPEUHDVWPLON LV
DOVRLQDIRUPWKDWLVPRUHHDVLO\ELRDYDLODEOHWRWKH\RXQJFKLOG7KHUHDIWHUWKHLQFLGHQFHRI
DQDHPLDLQFUHDVHVIURP±PRQWKVWLOOWKHFKLOGLV\HDUROG,Q,QGLDGLHWVIRUFKLOGUHQLQWKH
DJHJURXS±PRQWKVDUHSUHGRPLQDQWO\SODQWEDVHGDQGSURYLGHLQVXI¿FLHQWDPRXQWVRI
micronutrients to meet the recommended nutrient intakes. 
7KHIROORZLQJLQWHUYHQWLRQLVSURSRVHGIRUWKLVWDUJHWVHJPHQW
Dose and Regime
2QHPORI,)$V\UXSFRQWDLQLQJPJRIHOHPHQWDOLURQDQGPFJRIIROLFDFLGELZHHNO\IRU
GRVHVLQD\HDU,URQIROLFDFLGVXSSOHPHQWVZLOOEHVXSSOLHGLQERWWOHVRIPOHDFKDQG
FRPSRVLWLRQSUHSDUDWLRQGRVHDQGGXUDWLRQRI,)$VXSSOHPHQWDWLRQZLOOUHPDLQVDPHDVWKH
H[LVWLQJJXLGHOLQHV7KHERWWOHVVKRXOGKDYHDQDXWRGLVSHQVHUVRWKDWRQO\PORIV\UXSZLOO
EHGLVSHQVHGDWDWLPH
$OEHQGD]ROHWDEOHWVZLOOEHSURYLGHGWRFKLOGUHQIRUELDQQXDOGHZRUPLQJDVSHU7DEOH
6XSSOHPHQWDWLRQWKURXJKWKH/LIH&\FOH
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Table 6.2: Dosage of Albendazole tablets for biannual de-worming
Age 
Dose  
(Albendazole  
400 mg tablet) 
$SSURSULDWHDGPLQLVWUDWLRQRIWDEOHWVWRFKLOGUHQEHWZHHQ
WKHDJHVRIDQG\HDUVLVLPSRUWDQW7KHWDEOHWVKRXOG
EHEURNHQDQGFUXVKHGEHWZHHQWZRVSRRQVWKHQVDIH
ZDWHUDGGHGWRKHOSDGPLQLVWHUWKHGUXJ
1–2 years +DOIWDEOHW
\HDUVXSZDUGV 2QHWDEOHW
Note: Prophylaxis with iron should be withheld in case of acute illness (fever, acute diarrhoea, 
pneumonia etc.), Severe Acute Malnutrition (SAM) and in a known case of haemoglobinopathy/
history of repeated blood transfusion. 
Implementation
)RUDOOFKLOGUHQDJHGWRPRQWKVLWLVSURSRVHGWKDW,)$VXSSOHPHQWZLOOEHDGPLQLVWHUHG
XQGHUWKHGLUHFWVXSHUYLVLRQRIDQ$FFUHGLWHG6RFLDO+HDOWK$FWLYLVW$6+$RQ¿[HGGD\VRQD
ELZHHNO\EDVLV7KHPLFURSODQIRUUHDFKLQJRXWWRWKHVHFKLOGUHQFDQEHZRUNHGRXWDWYLOODJH
OHYHO ,W LVUHFRPPHQGHGWKDWDSDUWLFXODUFKLOGVKRXOGUHFHLYHWKHVXSSOHPHQWRQWKH¿[HG
GD\0RQGD\DQG7KXUVGD\WKRXJKLWFDQYDU\IRUWKHJURXSVRIFKLOGUHQGHSHQGLQJRQWKH
KRPHYLVLWVVFKHGXOHSUHSDUHGDWEORFNGLVWULFWOHYHO7KHQXWULWLRQDOVWDWXVRIFKLOGUHQVKRXOG
EHDVVHVVHGE\08$&0LG8SSHU$UP&LUFXPIHUHQFHOHVVWKDQFPWRHQVXUHWKDW,)$
V\UXSLVQRWJLYHQWRFKLOGUHQZLWK6HYHUH$FXWH0DOQXWULWLRQ6$0
$6+$ZRXOGJLYH,)$V\UXSERWWOHVWRPRWKHUVIRUVDIHVWRUDJHDQGWROHVVHQWKHORJLVWLFKXUGOH
RIFDUU\LQJERWWOHVDURXQGEXWWKH,)$V\UXSZLOOEHDGPLQLVWHUHGXQGHUKHUGLUHFWVXSHUYLVLRQ
RQO\'XULQJWKHYLVLWVWKH$6+$ZLOODOVRDGYLVHLQIRUPWKHFDUHJLYHUDERXWWKHIROORZLQJLVVXHV
 7LPHRIDGPLQLVWUDWLRQ±KDOIDQKRXUDIWHUIRRGLIWKHFKLOGKDVEHHQEUHDVWIHGLQ/%:
LQIDQWVIHGVHPLVROLGVROLGIRRG
 %HQH¿WVRIUHJXODULQWDNHRI,)$V\UXSLQSK\VLFDODQGFRJQLWLYHGHYHORSPHQWRIWKHFKLOG
HJLPSURYHPHQWLQZHOOEHLQJDWWHQWLYHQHVVLQVWXGLHVDQGLQWHOOLJHQFHHWF
 0LQRUVLGHHIIHFWVDVVRFLDWHGZLWK ,)$DGPLQLVWUDWLRQVXFKDVEODFNGLVFRORXUDWLRQRI
stools.
 3UHVHUYDWLRQ RI ,)$ ERWWOH ± LQ D FRRO DQG GDUN SODFH DZD\ IURP UHDFK RI FKLOGUHQ
NHHSLQJWKHOLGRIWKHERWWOHWLJKWO\FORVHGHDFKWLPHDIWHUDGPLQLVWUDWLRQHWF
Note: $6+$VIURQWOLQHZRUNHUVFDUHJLYHUVVKRXOGEHVSHFL¿FDOO\LQVWUXFWHGWRDGPLQLVWHU,)$VXSSOHPHQW
KDOIDQKRXUDIWHUWKHFKLOGKDVEHHQEUHDVWIHGLQ/%:LQIDQWVIHGVHPLVROLGVROLGIRRG
'HWDLOVRI,)$VXSSOHPHQWDWLRQZLOOEHLQFOXGHGLQWKH0RWKHUDQG&KLOG3URWHFWLRQ0&3&DUG
ASHAs will be suitably incentivised for undertaking this activity.
6XSSOHPHQWDWLRQIRU&KLOGUHQPRQWKVRQZDUG±\HDUV
,URQGH¿FLHQF\GXULQJFKLOGKRRGLVRIWHQFDXVHGE\LQDGHTXDWHGLHWDU\LQWDNHDEVRUSWLRQRU
XWLOLVDWLRQRILURQLQFUHDVHGLURQUHTXLUHPHQWVGXULQJWKHJURZWKSHULRGRUEORRGORVVGXHWR
SDUDVLWLFLQIHFWLRQVVXFKDVPDODULDDQGVRLOWUDQVPLWWHGZRUPLQIHVWDWLRQV
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7KHUDSHXWLF$SSURDFKWKURXJKWKH 
/LIH&\FOH
6L[0RQWKV±0RQWKV
$6+$VDQG$10VZLOOVFUHHQFKLOGUHQIURPPRQWKVXSWR\HDUVRIDJHIRUVLJQVRIDQDHPLD
DVSHU,QWHJUDWHG0DQDJHPHQWRI1HRQDWDODQG&KLOGKRRG,OOQHVV,01&,*XLGHOLQHVWKURXJK
RSSRUWXQLVWLFVFUHHQLQJDW
 VHNDs
 Immunisation sessions
 +RXVHWRKRXVHYLVLWVE\$6+$VIRUELZHHNO\,)$VXSSOHPHQWDWLRQ
 6LFNFKLOGFRPLQJWRKHDOWKIDFLOLW\6XEFHQWUH3+&
Screening through assessment of palmar pallorDVSHU,01&,JXLGHOLQHV  
,IWKHVNLQRIFKLOG¶VSDOPLVSDOHUWKDQWKDWRIRWKHUVWKHFKLOGZLOOEHUHIHUUHGWRWKHDSSURSULDWH
KHDOWKIDFLOLW\3+&0RELOH0HGLFDO7HDPVIRU+EHVWLPDWLRQDQGWUHDWPHQWRIDQDHPLD
Facility level management
 $Q\FKLOGUHSRUWLQJWRDQ\IDFLOLW\3+&OHYHODQGDERYHZLWKDQ\LOOQHVVZLOOEHDVVHVVHG
FOLQLFDOO\E\ WKHDWWHQGLQJ0HGLFDO2I¿FHU IRUDQDHPLDroutinelyDQGVKRXOGXQGHUJR 
+EHVWLPDWLRQLIIRXQGWREHDQDHPLFFOLQLFDOO\
 $OOFKLOGUHQUHIHUUHGIURP¿HOGFRPPXQLW\RXWUHDFKVXEFHQWUHWR3+&GXHWRSDOPDU
SDOORUZLOOXQGHUJR+EOHYHOHVWLPDWLRQEHIRUHLQLWLDWLQJWUHDWPHQW
&KLOGUHQZLOOEHFDWHJRULVHGDVKDYLQJPLOGPRGHUDWHDQGVHYHUHDQDHPLDRQWKHEDVLVRI 
+EOHYHOVDQGZLOOEHPDQDJHGDVSHU7DEOH
7
*XLGHOLQHVIRU&RQWURORI,URQ'H¿FLHQF\$QDHPLD
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Table 7.1: Management of anaemia on the basis of haemoglobin levels in children 
6 months–5 years
Level of Hb Treatment Follow-up Referral 
No Anaemia  
!JPGO
PJRIHOHPHQWDOLURQDQGPFJRIIROLFDFLGLQELZHHNO\UHJLPHQ
Mild Anaemia  
±JPGO
PJRILURQ
.JGD\IRU 
2 months
)ROORZXSHYHU\GD\VE\
ANM
+EHVWLPDWLRQDIWHU
FRPSOHWLQJPRQWKVRI
treatment to document 
+E!JPGO
In case the child has not 
responded to the treatment of 
DQDHPLDZLWKGDLO\GRVHRILURQ
for 2 months, refer the child to the 
)58'+ZLWK),01&,WUDLQHG02
Paediatrician/Physician for further 
LQYHVWLJDWLRQ
Moderate Anaemia  
±JPGO
PJRILURQ
.JGD\IRU 
2 months
)ROORZXSHYHU\GD\VE\
ANM
+EHVWLPDWLRQDIWHU
FRPSOHWLQJPRQWKVRI
treatment to document  
+E!JPGO
In case the child has not 
responded to the treatment of 
DQDHPLDZLWKGDLO\GRVHRILURQ
for 2 months, refer the child to the 
)58'+ZLWK),01&,WUDLQHG02
Paediatrician/Physician for further 
LQYHVWLJDWLRQV
Severe Anaemia  
JPGO
Refer 
XUJHQWO\WR
DH/FRU
Table 7.2: Dose of IFA syrup for anaemic children 6 months–5 years
Age of child Dose Frequency 
PRQWKV±PRQWKV±NJ 1 ml of IFA syrup Once a day 
\HDU±\HDUV±NJ PORI,)$V\UXS Once a day
\HDUV±\HDUV±NJ 2 ml of IFA syrup Once a day
Follow-up of children undergoing treatment of anaemia to be done by ANM
Monitoring by ASHA for compliance of IFA syrup every 
14 days for a period of 2 months
Follow-up by ANM every 14 days 
If child continues to have anaemia (Hb estimation at 
sub-centre) after 2 months of IFA syrup, refer the 
child to PHC - MO for further management 
7KHUDSHXWLF$SSURDFKWKURXJKWKH/LIH&\FOH
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 $IWHUFRPSOHWLRQRIWUHDWPHQWRIDQDHPLDDQGGRFXPHQWLQJ+EOHYHO!JPGOWKH,)$
VXSSOHPHQWDWLRQWREHUHVXPHG
 7UHDWPHQWRIDQDHPLDZLWKLURQVKRXOGEHZLWKKHOGLQFDVHRIDFXWHLOOQHVV6HYHUH$FXWH 
0DOQXWULWLRQDQGLQDNQRZQFDVHRIKDHPRJORELQRSDWK\$QDHPLDLQWKHVHFDVHVVKRXOG
EHWUHDWHGDVSHUWKHVWDQGDUGWUHDWPHQWJXLGHOLQHVE\WKHDWWHQGLQJSK\VLFLDQDVSHU
the merit of the individual case.
Management of severe anaemia at FRU/DH (as per F-IMNCI) in children  
6 months–5 years
History to be taken for Examination for 
'XUDWLRQRIV\PSWRPV
8VXDOGLHWEHIRUHWKHFXUUHQWLOOQHVV
)DPLO\FLUFXPVWDQFHVWRXQGHUVWDQGWKHFKLOG¶V
VRFLDOEDFNJURXQG
3URORQJHGIHYHU
:RUPLQIHVWDWLRQ
%OHHGLQJIURPDQ\VLWH
$Q\OXPSVLQWKHERG\
3UHYLRXVEORRGWUDQVIXVLRQV
6LPLODULOOQHVVLQWKHIDPLO\VLEOLQJV
6HYHUHSDOPDUSDOORU
6NLQEOHHGVSHWHFKLDODQGRUSXUSXULFVSRWV
/\PSKDGHQRSDWK\
+HSDWRVSOHQRPHJDO\
6LJQVRIKHDUWIDLOXUHJDOORSUK\WKPUDLVHG
-93UHVSLUDWRU\GLVWUHVVEDVDOFUHSLWDWLRQV
Investigations Indication for blood transfusion Blood transfusion 
)XOOEORRGFRXQWDQG
H[DPLQDWLRQRIDWKLQ¿OPIRU
FHOOPRUSKRORJ\
%ORRG¿OPVIRUPDODULD
parasites
6WRROH[DPLQDWLRQIRURYDF\VW
DQGRFFXOWEORRG
$OOFKLOGUHQZLWK+EJPGO
&KLOGUHQZLWK+E±JPGOZLWK
DQ\RIWKHIROORZLQJ
 – Dehydration
 – Shock
 – Impaired consciousness
 – Heart failure
 ±'HHSDQGODERXUHGEUHDWKLQJ
 ±9HU\KLJKSDUDVLWDHPLD 
!RI5%&
,ISDFNHGFHOOVDUHDYDLODEOH
JLYHPONJRYHU±KRXUV
SUHIHUDEO\,IQRWJLYHZKROH
EORRGPONJRYHU 
±KRXUV
Indications for further investigations and referral for management:
 &DVHV RI DQDHPLD DQG +HSDWRVSOHQRPHJDO\6SOHQRPHJDO\ LI PDODULD KDV EHHQ
H[FOXGHGRUQRWVWURQJO\VXVSHFWHG
 &KLOGUHQZLWKVLPLODUKLVWRU\LQWKHIDPLO\VLEOLQJV
 &DVHVRIDQDHPLDZLWKVLJQL¿FDQWO\PSKDGHQRSDWK\EOHHGLQJPDQLIHVWDWLRQV
 &DVHVRIDQDHPLDZLWKDEQRUPDOLPPDWXUHFHOOVRUPDUNHGOHXFRF\WRVLVRUELF\WRSHQLD
or pancytopenia on smear examination
 &KLOGUHQZKRDUHQRWUHVSRQGLQJWRDGHTXDWHGRVHRILURQIRODWHJLYHQIRUZHHNV
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Abstract
Background: Childhood anemia is highly prevalent worldwide. Improving the hemoglobin level of preschool age
children could yield substantial benefits in cognitive and psychosocial development and overall health. While evidence-
based recommendations for reducing childhood anemia in high anemia prevalence countries are available, there is no
experimental evidence of community centered education and counseling programs, as a route to improved acceptance
of iron supplements, demonstrating beneficial effects on anemia outcomes. We report on the evaluation protocol of a
complex educational intervention led by the community lay health worker (LHW) and delivered to mothers of 12–59-
month-old anemic children living in and visiting village day care centers in a large district of southern India.
Methods and design: The study is designed as a cluster randomized controlled trial. The intervention is based on the
social cognitive theory and aims to promote among mothers, anemia awareness, dietary modifications to increase iron
intake in the child, and recognition of the need for enhanced adherence to supplemental iron in the anemic child. From
270 eligible villages in the study area, a sample of 60 villages will be randomized to intervention [n = 30] or to treatment
as usual [n= 30] of the study. LHWs in the intervention arm will be trained to administer the following intervention
components to mothers of anemic children: 1] monthly distribution of Iron and folic acid (IFA) supplements to mothers
of anemic children, and 2] five monthly counseling sessions of mothers of anemic children covering: a] anemia awareness
education b] IFA adherence counseling and assessment, c] dietary modification to improve iron intake, and d] hygiene
and sanitation. LHWs in the control arm will distribute IFA to mothers of anemic children as in the intervention arm but
will not provide monthly education and counseling support. The primary outcome is the difference between the two
experimental groups in anemia cure rates of children found to be anemic at baseline. Secondary outcomes, assessed as
differences between all participants in both experimental groups, are: change in mothers’ knowledge regarding anemia;
24 hour dietary iron intake; net improvement in individual hemoglobin values; serum ferritin; and the difference in overall
cluster level childhood anemia prevalence. All outcomes will be measured 6 months after the start of the intervention.
Multilevel linear and logistic regression models will be used to analyze differences between intervention and control
groups in outcome variables.
(Continued on next page)
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Discussion: This trial is designed to evaluate the effectiveness of an intervention intended to improve anemia cure
rates in anemic children living in villages of Chamarajnagar, Karnataka a large district in south India. The extensive study
of secondary endpoints will be used to identify possible weak points in the compliance to intervention delivery and
uptake. This evaluation is one of the few large randomized trials evaluating the impact of an education and counseling
intervention to reduce childhood anemia prevalence.
Trial registration: This trial was registered with ISRCTN.com (identifier: ISRCTN68413407) on 17 September 2013.
Keywords: Iron deficiency anemia, Hemoglobin, Cluster randomization, Controlled trial, Counseling, Evaluation
Background
Over 1.6 billion people worldwide suffer from anemia and
approximately 80 % of the burden of this disorder is borne
by individuals living in South Asia and Africa [1–3].
Anemia is associated with a significant economic burden
[4], accounts for 68.4 million years lived with disability
(8.8 % of total for all conditions), increased maternal and
perinatal mortality, and contributes to global mortality
[5–7]. The prevalence of anemia in India is particularly
high, where 50 % of reproductive age women, 59 % of
pregnant women, 25 % of men, 40 % of adolescent girls,
and 70 % of children under five years are anemic [8, 9].
The etiology of childhood anemia in limited resource
settings is multifactorial [10–12], but in India it is mainly
attributable to iron and other micronutrient deficiencies
[6, 9, 13–15]. Iron deficiency anemia (IDA) is associated
with cognitive and psychomotor retardation in children
[16, 17], and trials of iron supplements in iron deficient
children demonstrate improved outcomes [18]. The major
cause of IDA in India is inadequate iron intake due to
both low dietary iron content of food [19] and inadequate
dietary animal protein [20]. In this context, childhood
anemia appears to be mostly influenced by maternal
anemia during pregnancy [8], poor nutritional and dietary
iron intake [9, 19], and a combination of adverse socioeco-
nomic factors [9].
Public health strategies addressing IDA have concen-
trated efforts on improving dietary iron intake by pro-
moting population-based iron supplementation and
diversification of diets, and by improving the iron con-
tent of food by fortification [21, 22]. These efforts have
successfully reduced anemia prevalence in other Asian
settings [20], but such benefits have not accrued in
India [23, 24]. In line with WHO recommendations,
the Indian government iterated the National Nutri-
tional Anemia Control Programme (NNACP), which
featured the use of iron supplements [21, 24]. More re-
cently, launching of the national Iron + initiative by the
Indian government has made anemia control more
comprehensive by including an emphasis on nutrition
[25]. Globally, however, challenges to childhood anemia
control remain [26]. In India, inadequate procurement
and distribution of iron and folic acid (IFA)[27], a
perceived lack of adequate lay health worker (LHW)
support in the village [27–29], and unfounded beliefs
and psychological issues among individuals [9, 27]
appear to hamper effective childhood anemia control.
Previous research has shown that LHW-led education
interventions are effective at promoting dietary modifi-
cation, complementary feeding, and immunization
uptake among rural communities [30–35]. We hypoth-
esized that an educational and counseling intervention
with a strong parental component specifically to reduce
knowledge gaps among mothers, improve parental self-
efficacy, and enhance adherence of the anemic child to
(IFA would achieve better anemia cure rates than treat-
ment as usual. This paper describes the study protocol
for the Karnataka Anemia Project 2, which evaluates
the effectiveness of a community LHW-led educational
and counseling intervention delivered to mothers of
anemic children residing in villages located in a prov-
ince of southern India. We follow the CONSORT state-
ment for reporting of cluster randomized trials [36, 37].
Design and Methods
Study design and setting
The study is designed as a cluster randomized con-
trolled trial (CRCT) set in the Chamarajnagar taluk,
Chamarajnagar district of Karnataka state, India.
Karnataka, a south western state with a population of
61 million (7.1 million of which are children 0–6 years
of age) is the ninth most populated state in India
(2011 census) [38]. The study area, Chamarajnagar
district, is located in a rural setting with a predomin-
antly agrarian economy and an average annual house-
hold income of Indian rupees (INR) 22 006 (US $478)
reflecting state and national averages. The Karnataka
average annual household income is INR 26 123 (US
$567), and the Indian overall average annual house-
hold income is INR 25 825 (US $561). Literacy rates
are slightly higher (total = 75 % M = 82 %; F = 66 %)
than the national average.
In India, the Integrated Child Development Service
(ICDS) runs a network of village-based child care cen-
ters (ADCs), caring for children up to age 6 years and
potentially offering the setting in which to deliver health
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interventions to mothers of registered children [35]. The
LHW in charge of the ADC is an integral component of
the health system whose routine work includes the
maintenance of childhood immunization records, health
education for mothers, as well as kindergarten education
for all village children. From the age of 36 months,
children attend the ADC and receive day care services,
education, and nutritional supplements under a govern-
ment funded ICDS scheme. Although children younger
than 36 months are registered in the ADC, for practical
reasons they are not encouraged to attend. Typically the
ADC LHW lives in the village, has a good relationship
with mothers of children below 6 years of age, and an
overall good standing in the community.
In this trial, a cluster (randomization unit) will be
defined as a village in the Chamarajnagar subprovince
that is randomly allocated to one of the study arms
together with the ADC or (if the village has more than
one ADC) the selected ADCs belonging to that village,
and the corresponding LHW in charge of the ADC.
Using a computerized random number generator [39],
60 villages from a total of 270 eligible villages will be
randomly selected. The villages will be stratified based
on the number of <6 year-old children listed in the ADC
registers as resident in each village. After stratification,
the selected villages will be assigned to intervention and
control arms of the trial using a 1:1 ratio, in order to
ensure equal representation of both strata to both arms.
The observational units consist of children aged 12–59
months registered in the randomized villages and their
mothers/caregivers, eligible for the study. We plan to
recruit all eligible children (Fig. 1).
Participants
All children aged 12–59 months, residing in the village
and registered in the village ADC, will be eligible to
participate in the trial.
Inclusion criteria
For enrollment, children should be accompanied by their
mother or caregiver. Mothers/caregivers of participants
in the intervention arm should consent to receive LHW-
led intervention and intend to reside in the village for at
least 6 months after enrollment in the trial.
Exclusion criteria
Children with severe anemia defined as Hb ≤ 7.9 gm/dl
for the purpose of this trial [40] will be excluded and re-
ferred to the primary health center/first referral unit for
assessment and medical management. Children with a
reported history of an active infection or fever >101 °F
will also be excluded from participation and referred to
the primary health center/first referral unit for manage-
ment as usual.
Intervention
Rationale for the intervention and its development
In the planning stage of the intervention, theoretical
frameworks were developed according to Fraser et al
[41]. In the Problem Theory, the mother’s knowledge,
attitude, beliefs, care and control, role model, willing-
ness to change, and parental self-efficacy were identi-
fied as malleable factors in order to influence the
hygiene, dietary habits, and adherence to IFA supplements
in their children. The design of the intervention is guided
by the Social Cognitive Theory (SCT) [42], based on evi-
dence in the published literature [23, 29, 31, 33, 34, 43, 44],
and modulated based on discussions with stakeholders and
policymakers in the Karnataka. According to the SCT, at
least two principal sources of self-efficacy: verbal persuasion
and performance accomplishment, are intended to mediate
the effect of this intervention. The education of mothers
about anemia, nutrition, IFA supplementation, and hygiene
could foster the perception that their actions can control
anemia in their children. This would lead to positive
expectations about their children’s health outcomes, which,
along with LHW facilitation of learning and positive
reinforcement, could improve IFA adherence (Fig. 2).
Furthermore, the intervention benefits are hypothe-
sized to spill over to the entire community. Following
a socio-ecological framework [45, 46], the child’s im-
mediate environment affected by the intervention
would be the microsystem (the family) and the meso-
system (for example, parent-teacher meetings, the
neighborhood, and social gatherings at the village
level). At both these levels, one could expect coun-
seled mothers of anemic children to modify the behav-
iors of mothers of non-anemic children, with respect
to IFA consumption and dietary iron intake, thereby
reducing the overall prevalence of anemia at the clus-
ter level. Thus, the intervention is evidence based,
contextually relevant, uses locally relevant resources,
and has the potential to influence national policy.
Lay health worker training
LHWs in the intervention villages [n = 30] will receive
training under four separate hands-on workshops over a
period of 6 months. Training will occur with the use of
role play, facilitation, and flip charts to help develop coun-
seling and education skills of the LHWs. Training will take
place at a location different from the LHWs’ habitual
training/supervision sites, to minimize the risk of contam-
ination. LHWs will be trained to deliver five monthly edu-
cation and counseling sessions to mothers/caregivers of
anemic children. Specifically, these sessions will aim to
improve mothers’ knowledge regarding anemia and its
consequences, the treatment of iron deficiency anemia
with IFA, the importance of adherence to IFA treatments,
sources of iron-rich food, diet modification behaviors, and
Shet et al. Trials  (2015) 16:599 Page 3 of 10
hygiene. The possibility of contamination during LHW-
supervisor monthly meetings, due to interaction between
control group and intervention group LHWs, is minimal.
LHWs in the control group neither receive training nor
have access to training and intervention materials and will
therefore be unable to replicate the intervention in their
villages.
Components of the Intervention
i) Enrollment and screening for anemia
All eligible participants providing informed consent
will be enrolled in the trial, provide information for
a baseline questionnaire, have anthropometric
measurements, and venous blood obtained by
Fig. 1 Study schematic of the Karnataka Anemia Project 2 study to evaluate a community-based parental intervention to improve childhood
anemia cure rate
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phlebotomy to screen for anemia by the research
team.
ii) Iron supplementation
A core preventive measure common to both trial
arms is the delivery of iron supplements. All
enrolled non-anemic participants are eligible for
IFA supplements (tablets containing 20 mg elem-
ental iron, 8 tablets/month) in line with National
Iron + guidelines [25]. The guidelines recommend
20 mg IFA dispensed as syrup biweekly through-
out the period 6–60 months and deworming for
children 12 months and older. Since IFA syrup
was not available in Karnataka, for the purpose of
this trial, IFA is provided as 20 mg tablets. All
enrolled participants detected with anemia (Hb ≥ 8
and ≤ 11 gm/dL) [40] in both arms of the trial are
eligible for the therapeutic IFA dosage to control
iron deficiency anemia (tablets containing 20 mg
elemental iron, 20 tablets/month for 5 months).
All subjects with acute infections or fever will be
excluded during enrollment to the trial. Further-
more, during dispensation of IFA tablets, LHWs
will advise mothers to withhold these during pe-
riods of fever or acute infections.
iii)Education and counseling
Only mothers/caregivers of anemic children (Hb ≥ 8
and ≤ 11 gm/dL) in the intervention arm will receive
five monthly education and counseling sessions
delivered by the LHW over the 6-month interven-
tion period (Fig. 1).
iv)Monitoring of adherence to IFA
From the second counseling visit onward, LHWs
in the intervention arm perform monthly pill
counts to assess adherence to IFA dispensed only
to mothers/caregivers of anemic children in the
previous month and document the side effects of
IFA, if any. In accordance with precautions in the
guidelines, LHWs will advise mothers to withhold
supplemental and treatment IFA during periods of
fever or acute infections. A similar monthly
assessment of adherence for mothers of anemic
children in the control arm will not be
performed. However, at the end of the 6 months
of intervention, an assessment adherence to IFA
in the previous 30 days will be performed for all
participants in both arms of the trial.
Outcomes
The primary outcome will be the difference in anemia
cure rate between the experimental arms at the end of
Fig. 2 Hypothesized causal pathway of the effect of the intervention and its outcome measures
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6 months from the intervention’s start, in children found
to be anemic at baseline. In addition, we will assess sev-
eral secondary outcomes occurring along the hypothe-
sized causal pathway of the intervention effect (Fig. 2),
including: 1) difference in changes of knowledge and
practice of mothers of anemic children from baseline to
follow-up, 2) differences in the estimated 24-hour diet-
ary iron intake among anemic participants exposed and
not exposed to the intervention, 3) difference in net im-
provements in individual hemoglobin values between
baseline and 6 month follow-up among anemic children
exposed and not exposed to the intervention, 4) net im-
provements in mean ferritin values among anemic par-
ticipants exposed and not exposed to the intervention,
and, 5) difference in the cluster level anemia prevalence
between experimental arms. Additional process indicator
data include evaluation of the proportion of expected
IFA doses delivered to children in the study (adherence
to iron treatment), maintenance of LHW records of de-
livery of the intervention and IFA, and recording of the
incidence of side effects of IFA supplements in children.
Qualitative research on the acceptability, perceptions,
and experiences of the LHWs regarding the training for
and the actual delivery of the intervention will be con-
ducted using focus group discussions. These data will
help identify key assumptions and limitations of under-
lying intervention feasibility and sustainability and
scaling-up, particularly when involving LHWs at the
national level.
Protocol of recruitment
From the list of all children < 6 years registered in each
village by the LHW in charge of the ADC, the research
team will generate an eligible 12–59 month child list.
Using this list, the LHW will mobilize participants and
their mothers to the village ADC for study enrollment.
Recruitment will occur at the village ADC and last for
approximately 2 days. Additional house visits will be
made on recruitment days to identify reasons for non-
attendance of participants on the list (for example, those
who are too sick, traveling, or migrating] and to help
mobilize those who forgot to visit the ADC. Mothers/
caregivers of all eligible children, who after being pro-
vided information about the trial indicate willingness to
participate and an intention to live in the village for at
least 6 months after enrollment, and those in the inter-
vention arm indicating a willingness to receive LHW-led
counseling will be enrolled after providing written in-
formed consent (Fig. 1). Where recruitment is <80 % of
the eligible list, an additional recruitment day will be al-
located. Children who do not fulfill the inclusion criteria
during recruitment sessions are not eligible for future
recruitment.
Protocol of data collection
At study entry, a baseline questionnaire will record par-
ticipant information. An additional file shows this in
more detail [see Additional file 1]. Participants will also
have a baseline sample of anticoagulated venous blood
obtained to detect anemia and measure serum ferritin.
All recruited participants will have a hemoglobin value
estimated using an automated cell counter (Sysmex
405, Transasia laboratory systems, Japan). Within a few
days the research team will provide mothers/caregivers
with results of the hemoglobin values and anthropom-
etry, and cluster LHWs with a list of anemic and non-
anemic children. The list will permit LHWs in each
cluster to organize the delivery of dose appropriate IFA
to anemic and non-anemic children and to identify
mothers of anemic children for delivery of monthly
education and counseling.
The date of delivery of the first month’s supply of IFA
to the mothers of children in a cluster will herald the
start of the intervention in that cluster. LHWs will de-
liver IFA to mothers of non-anemic children at the ADC
during routine monthly visits. LHWs will typically de-
liver IFA together with education and counseling to
mothers of anemic children at their homes. From the
second visit onward, adherence data will be collected by
the LHW, and the remaining IFA pills/empty strip will
be obtained from the mother. In the control arm, LHWs
will deliver IFA as usual in the setting of the ADC and
will not deliver education and counseling to mothers of
anemic children or collect monthly IFA adherence data.
Approximately 6 months from the day of delivery of the
first IFA supplement, the research team will perform a
follow-up visit to collect 24-hour dietary recall data,
anthropometry, and information on adherence to IFA in
the previous month from all enrolled participants.
During this time, a repeat phlebotomy to estimate
hemoglobin is performed for all participants in the clus-
ter, and the trial is completed.
Questionnaires prior to and after the intervention
from mothers of anemic children provide information
about the impact of LHW-delivered education and
counseling on the mother’s knowledge regarding
anemia and its effects on the child. The mother’s
knowledge and practice questionnaire was explored by
pilot testing it in the field for ease of administration
and understanding. Assessment of 24-hour dietary
iron intake at baseline and at the end of the interven-
tion will provide information to estimate the effect of
this intervention on promoting dietary diversification
and improving dietary iron content. Finally, assess-
ments of ferritin, a serum marker of iron stores, will
provide information on whether actual improvements
have been made in the total body iron stores of
anemic children.
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Statistical methods
Statistical power and sample size calculation
Primary analyses are limited to children with anemia at
enrollment. At the end of 6 months, a difference of at
least 12 % in the cure rate of anemic children is required
if the intervention is considered to have sufficient public
health utility to warrant its cost and effort [47–49]. We
estimate that the 12 % reduction in proportion of
anemic children at 6 months would occur due to a cure
rate of 30 % in the control group (IFA alone) and 42 %
in the experimental arm where children receive IFA plus
the community-based parental intervention. To detect a
12 % difference in 6-month anemia cure rates at an
alpha level of 0.05 for a two-tailed test, with 80 % power,
a total unadjusted sample size of 500 children with
anemia is required, which after adjustment for clustering
(design effect = 2.2) results in a sample size of 1,100
children with anemia. The design effect assumes an
intracluster correlation coefficient (ICC) of 0.05 and 25
participating children with anemia per village. The antic-
ipated degree of intracluster correlation was selected
based on results from several recent trials of interven-
tions on anemia [47–49]. We further allow for a 10 %
loss to follow-up of children identified with anemia at
baseline, yielding a final sample size of 610 children with
anemia per arm (1,220 in all). We will recruit 30 clusters
per trial arm to accommodate potential losses of clusters
if LHWs should stop working, resulting in loss of an
entire cluster. Thus, power will be greater than 80 %.
Analyses will also consider prevalence of anemia at
6 months among all participating children regardless of
their baseline anemia status. Based on an estimated
prevalence of 50 % anemia at baseline in each village,
the number of children required will be 1,220 in each
trial arm.
Statistical analysis
The primary analysis will follow the intention-to-treat
principle, whereby all children regardless of whether
they received the full intervention or not will be in-
cluded in the analysis of the group to which they
were randomized. Data will be analyzed at the indi-
vidual level adjusting for clustering using generalized
estimating equation (GEE) extensions of logistic re-
gression for presence or absence of anemia while
similar extensions of linear regression will be used to
model individual hemoglobin levels [50]. All models
will adjust for the stratification factor (the number of
children per village). The effects of explanatory vari-
ables such as age, sex, socioeconomic status, literacy,
nutritional parameters, and maternal anemia status
will also be explored. Secondary analyses will consider
the effect of adjustment for these potential explana-
tory variables on the estimated intervention effect
using multivariable regression models. All tests will
be declared statistically significant at the 0.05 level
(two-tailed).
Ethical issues
Ethical approval
The study was approved by the St. Johns National
Academy of Health Sciences Institutional Ethical
Committee (IEC 115/2012).
Information and informed consent
Information about the trial is provided to community
leaders and mothers through the LHW. Written and
verbal information about the trial is provided in English
and Kannada (the local language). Documents trans-
lated into Kannada are validated through back transla-
tion. All participant mothers/care providers are
provided with study information prior to enrollment
for review. Individual informed consent is obtained
from mothers/care providers of selected children, and
is recorded by signature or thumbprint. Mothers/care
givers will also be informed that participation of their
child in the study is completely voluntary and that they
may withdraw from the study at any time.
Monitoring of side effects and trial supervision
Details regarding side effects to IFA supplements will
be collected by the LHW and notified to the research
team. In the event of side effects that are deemed re-
lated to IFA (either by the LHW or the research team),
participants are advised by the LHW to discontinue
IFA and report to the primary health center for evalu-
ation. Since the intervention under comparison is non-
invasive, the IFA supplements in the protocol follow
national recommendations, and the setting is not a
malaria endemic region, the occurrence of serious ad-
verse events (SAEs) is unlikely. An interim analysis of
the trial will take place when all subjects have been
recruited and all 30 clusters have completed 3 months
of delivery of the intervention. This analysis will be
conducted in a blinded manner by an independent data
safety and monitoring board (DSMB) consisting of
experts in clinical medicine, epidemiology, and statis-
tics. The primary aim of the interim analysis is to assess
if the intervention arm shows a clearly better, or worse,
outcome than the control arm as well as to evaluate
SAEs.
Discussion
This is the first cluster randomized control trial
(CRCT) designed to evaluate an intervention that in-
cludes both lay health workers and parents to comple-
ment India’s existing national health policy for
combating anemia in children, one of the most
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pernicious and common nutritional health burdens
among individuals in resource-limited settings [3, 6,
10, 51]. The present evaluation adopts a theory-based
approach to investigate the causal chain through
which the proposed intervention is expected to have
its impact (Fig. 2). We employ qualitative methods to
understand the perceptions and experiences of LHWs
actually delivering the intervention and the context
and process of the interventions delivery [52]. Results
from this contextually relevant intervention will be
used to establish whether it is possible to improve
anemia cure rates in anemic children in India with
relatively limited efforts targeted to the mothers of
such children.
The CRCT design, whereby groups of individuals are
randomly allocated to different interventions, has the po-
tential to provide unbiased estimates of the impact of in-
terventions delivered at the community level (in this case
children in a village eligible to attend the village day care).
A major strength of this trial is that it attempts to
maximize participation at both the cluster and individual
levels. For instance, LHWs in both arms of the study will
be provided with training, support, and resources to
achieve intervention goals, and will encourage cluster-
level participation to minimize drop-out rates. Further-
more, randomization will be an inclusive process with ac-
tive involvement and participation of the LHWs. During
recruitment, the research team will actively support
LHWs during periods of stress (wage-related agitations,
unscheduled ADC closures for local holidays, and breaks
during which LHWs perform other tasks such as
immunization). The research team will perform door-to-
door visits for eligible children who failed to attend the
ADC after mobilization by the LHW to identify reasons
for the mothers’ lack of attendance. Analysis of all this
data will provide clarity regarding participation in this trial
and could address concerns related to selection bias.
Anemia has been a public health problem for several de-
cades [3, 6] and is in great need of effective control pro-
grams. India bears a large portion of the burden of anemia
in Asia, with close to 100 million anemic children [2, 6].
The need for effective intervention studies addressing
anemia is particularly relevant to rural Indian communities,
where the prevalence of anemia is highest. However, there
is an increasing appreciation that such studies should not
only evaluate if interventions work, but also how they work,
thereby enhancing the policy implications of such evalua-
tions [52, 53]. In order to maximize policy relevance, it is
essential to understand the context of the research, the re-
lated policymaking processes and to engage key stake-
holders. To achieve this, we intend to continuously engage
with the health authorities at state, provincial, and district
levels. Inadequate IFA supplies have been previously noted
to be a major limitation to the success of anemia control in
low-middle income settings [28]. Thus, instead of procuring
IFA commercially, the Karnataka state health officials will
be involved and the state infra-structure will be utilized to
ensure that IFA is made available for the trial. These efforts
could eventually lead to greater sensitization of the health
department regarding IFA availability and recognition of
the need for enhanced LHW capacity to screen and man-
age anemia in Karnataka. Conducting research in rural
communities, especially in an Indian context, raises a num-
ber of practical and logistic issues. The research team has
partnered with an experienced field research agency that
has an established track record of development research in
the Chamarajnagar district. This team will work collabora-
tively, coordinate with the government, involve community
leaders from villages in the study area, and make partici-
pants stakeholders in their healthcare, all of which will con-
tribute to the successful conduct of the trial.
Indeed, the novelty of this cluster RCT consists of its
real-life setting evaluation of education and counseling
combined with monitoring of parental compliance in
connection with the delivery of IFA supplements to at-
tenuate the public health problem of childhood anemia.
All intervention components will be delivered by a com-
munity LHW, therefore relying on local human re-
sources. Furthermore, the intervention will use healthy
local dietary practices to positively influence the nutri-
tional behaviors of children and parents. If successful,
such an approach could profoundly shift the attention of
anemia control policy towards a diet-focused rather than
a supplementation-focused approach. Once effectiveness
in real-life conditions is ascertained, all the above fea-
tures of the intervention will collectively ensure high
potential for sustainability and scaling-up of the inter-
vention. The intervention may lead to improved
hemoglobin values and reduced anemia prevalence
among 12–59-month children in the short term [18, 26]
and could result in better cognitive outcomes in these
children over the long term [18, 54–56]. If effective, the
intervention could be implemented on a larger scale to
determine if such local effects may have a wider positive
health effect nationally. Final results from this interven-
tion trial are expected in mid-2016.
Trial status
The trial commenced recruitment in November 2014
and intends to complete recruitment in July 2015.
Additional file
Additional file 1: Baseline questionnaire. (PDF 287 kb)
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MESSAGE (SHOW PICTURES): 
Below normal levels of haemoglobin in red blood cells results in anemia.  
Pictures 1, 2:  Fewer red blood cells in anemic children, visibly less reddish colour of red blood 
cells due to lack of haemoglobin. Inadequate amounts of iron in food commonly cause anemia. 
Sufficient iron in food usually results in production of haemoglobin.   
Pictures 3, 4: Normal iron intake and hemoglobin levels will lead to normal growth and brain 
development. Anemic children will not grow as strong or as be as smart as children without 
anemia. 
CHECKING QUESTIONS:  
• What is anemia?
• How can anemia effect the growth of the child ?
MOTIVATION:  
• Children without anemia will be stronger and smarter. 
REMINDERS: If you think your child has anemia, tell the anganwadi worker and she will test 
your child.  
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MESSAGE: (SHOW PICTURES) 
Picture 1: If anemia is not corrected, the blood becomes weak. Many parts of the body 
(especially the brain) will not develop properly. Children may feel easily tired and may not play 
well. They may look pale and sometimes eat unusual things like mud, paint, and chalk.  
• Baby: low birth weight, more prone to infections 
• Children: slow body growth, low intelligence, poor school performance
• Pregnant women: maternal deaths, problems in pregnancy and delivery, longer time to
recover after delivery 
Picture 2: Anemia is correctable and you can identify and treat anemia if you know the signs 
and symptoms.  
CHECKING QUESTIONS:  
• What can happen if the child has anemia ?
MOTIVATION:  
• Children without anemia fall sick less often and are stronger and smarter in school. 
REMINDERS: Ask your anganwadi worker to test your child for anemia 
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MESSAGE: (SHOW PICTURES):  
The signs of anemia are: 
• Pictures 1, 2 and 3: Pallor, i.e., decreased pinkness, of skin of the palms, nail beds, lips, and
lining of the eyelids.  
• Picture 4: Tiredness all the time, weakness, irritability 
• Picture 5: Poor performance in school
• Loss of concentration and attention, developmental delays, behavioural disturbances 
• Breathlessness, rapid heartbeat, giddiness, lightheadedness 
CHECKING QUESTIONS: 
• What are the signs of anemia ?
MOTIVATION:  
• Looking for the signs of anemia in yourself and your child can help you to ask your 
anganwadi worker for help before you or your child becomes very sick.  
REMINDERS: Your anganwadi worker can test if you or your child has anemia. 
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BASELINEASSESSMENTFORM
(Completedbyresearchteamatbaselineforallparticipants)
Date:
   Village ID   PID (dd) (mm) (yyyy)
 ºÀ½îAiÀÄ ¸ÀASÉå   ¸ÀASÉå   ¢£ÁAPÀ: 
Villagename:
_______________________
Activity
done
Interview/Labs QC
Data
Entry1
Data
Entry2
Person’s
Initials
Date
A. Participantdetails: ¨sÁUÀªÀ»¹zÀªÀgÀ ªÀiÁ»w:
A1 Child’s name:
ªÀÄUÀÄ«£À ºÉ¸ÀgÀÄ: 
A2 Sex:°AUÀ:
1.Male 2.Female
A3 Dateofbirth:ºÀÄnÖzÀ ¢£ÁAPÀ 
____/____/________ 
ddmmyyyy
A4 Age:ªÀAiÀÄ¸ÀÄì:
______yrs______months
(eg:“2yr 3mon”) 
A5 Nameofcare­giver:¥ÉÆÃμÀPÀgÀ ºÉ¸ÀgÀÄ A6 Relationshipofcare­givertochild:
¥ÉÆÃμÀPÀgÀ eÉÆvÉV£À ¸ÀA§AzsÀ:
1. Mother(vÁ¬Ä)
2. Others,specify:______________
EvÀgÉ: £ÀªÀÄÆ¢¹:
B. Socio­demographicquestions(mother): ¸ÁªÀiÁ£Àå ªÀiÁ»w (d£À¸ÀASÉåUÉ ¸ÀA§A¢ü¹zÀAvÉ)
B1 Mother’s age :
vÁ¬ÄAiÀÄ ªÀAiÀÄ¸ÀÄì: 
____________(e.g. “25 yr”) 
Deceased(ªÀÄgÀtªÉÇ0¢ÝzÀgÉ)
B2 Mother’s religion: vÁ¬ÄAiÀÄ zsÀªÀÄð:
1.Hindu 2.Muslim 3.Christian
1. »AzÀÆ 2. ªÀÄÄ¹èA 3. Qæ²ÑAiÀÄ£ï
4. EvÀgÉ: £ÀªÀÄÆ¢¹:
4. Other,specify:_________________
B3 No.ofyearsofschooling:
___________years
¤ÃªÀÅ JμÀÄÖ ªÀμÀð ±Á¯ÉUÉ ºÉÆÃV¢ÝÃgÁ? 
B4 Canyouread:1. Yes 2.No
¤ªÀÄUÉ NzÀ®Ä §gÀÄvÀÛzÉAiÉÄ: 1. ºËzÀÄ 2. E®è
Canyouwrite:1.Yes 2.No
¤ªÀÄUÉ §gÉAiÀÄ®Ä §gÀÄvÀÛzÉAiÉÄ: 1. ºËzÀÄ 2. E®è
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C. Anemiariskfactors(mother):

C1 Howmanypregnancieshaveyouhadso
far?
¤ÃªÀÅ E°èAiÀÄ ªÀgÉUÉ JμÀÄÖ ¨sÁj UÀ©üðtÂAiÀiÁV¢ÝÃgÀ? 
Numberofpregnancies:__________
No.ofabortions/stillbirth:__________
(ifany)
C2 Couldyoutellmethebirthorderofthis
childamonglivebirths?
fÃªÀ0vÀªÁV ºÀÄnÖzÀ ªÀÄPÀÌ¼À°è F ªÀÄUÀÄ 
JμÀÖ£ÉAiÀÄzÀÄ? 
Numberoflivebirths:___________ 
Birthorder:_________
   
 
D. Anemiariskfactors(child) gÀPÀÛ»Ã£ÀvÉAiÀÄ ®PÀëtUÀ¼ÀÄ (ªÀÄUÀÄ) 
 
D1 Didyoubreastfeedthischild?
¤ªÀÄä F ªÀÄUÀÄ«UÉ JzÉ ºÁ®Ä PÀÄr¹¢ÝÃgÁ? 
1.Yes2.No(If ‘No’ goto D7)

      1. ºËzÀÄ      2. E®è   (E®è JAzÀgÉ D7PÉÌ ºÉÆÃV) 
D2 Forhowmanymonthsdidyougivethe
childbreastmilkalone,withnoother
foods(exclusivebreastfeeding)?

____________months

¤ªÀÄä ªÀÄUÀÄ«UÉ ¨ÉÃgÀ AiÀiÁªÀÅzÉ jÃwAiÀÄ DºÁgÀªÀ£ÀÄß 
¤ÃqÀzÉ §j JzÉ ºÁ®£ÀÄß JμÀÄÖ wAUÀ¼ÀªÀgÉUÉ 
¤Ãr¢ÝÃgÁ? 
D3 Areyoustillbreastfeedingthischild?
FUÀ®Ä ¤ÃªÀÅ F ªÀÄUÀÄ«UÉ JzÉ ºÁ®Ä 
PÀÄr¸ÀÄwÛ¢ÝÃgÁ? 
1. Yes2.No
(If ‘No’, goto D7)

1.  ºËzÀÄ (E®è JAzÀgÉ D7 PÉÌ ºÉÆÃV)  
2.  E®è 
D4 Howmanytimesdoyoubreastfeedthe
childinaday?
M0zÀÄ ¢£ÀzÀ°è ¸ÀÄªÀiÁgÀÄ JμÀÄÖ ¨Áj F ªÀÄUÀÄ«UÉ 
JzÉºÁ®Ä PÀÄr¸ÀÄwÛjÃ? 

1. 2times
2. 2­4times
3. >4times

D5 Howlongdoyoufeedthebabyonan
averageinaday?
M0zÀÄ ¢£ÀzÀ°è ¸ÀªÀiÁ£ÀåªÁV JμÀÄÖ ¸ÀªÀÄAiÀÄ F 
ªÀÄUÀÄ«UÉ JzÉºÁ®Ä PÀÄr¸ÀÄwÛjÃ? 

1. 5­10min
2. 10­20min
3. >20min
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                                                                      PID
D6 Forthischildatwhatagedidyoustop
breastfeedingaltogether?

Age:____________months

¤ªÀÄä F ªÀÄUÀÄ«UÉ AiÀiÁªÀ ªÀAiÀÄ¹ìUÉ JzÉ ºÁ®Ä 
PÀÄr¸ÀÄªÀÅzÀ£ÀÄß ¤°è¹¢ÝÃgÁ? 
    ªÀAiÀÄ¸ÀÄì___________wAUÀ¼ÀÄUÀ¼À°è. 
D7 Atwhatagedidyoufirstgiveother
foodsforthischild?

Age:____________months

¤ªÀÄä F ªÀÄUÀÄ«UÉ AiÀiÁªÀ ªÀAiÀÄ¹ì£À°è 
 ¥ÀÆgÀPÀ DºÁgÀªÀ£ÀÄß PÉÆqÀ®Ä ¥ÁægÀA©ü¹¢ÝÃj? 
ªÀAiÀÄ¸ÀÄì___________wAUÀ¼ÀÄUÀ¼À°è. 

Notyetstarted(E£ÀÆß ¥ÁægÀA©ü¹®è)
D8 Hasthechildevertestedfor
anemia(weakness)before?

1.Yes2.No3.Unsure

 ¤ªÀÄä ªÀÄUÀÄ«UÉ E°èAiÀÄªÀgÉUÉ AiÀiÁªÀÅzÁzÀjÃwAiÀÄ 
gÀPÀÛ»Ã£ÀvÉAiÀÄ (¸ÀÄ¸ÀÄÛ, DAiÀiÁ¸À) ¥ÀjÃPÉëAiÀÄ£ÀÄß 
ªÀiÁr¹¢ÝÃgÁ? 
    1. ºËzÀÄ  2. E®è    3. £É£À¦®è
D9

Hasthechildeverreceivediron/folic
acidtabletsorsyrup?
(Interviewerprompt:visualcue)
1. Yes2.No3.Unsure
(If ‘Unsure/No’, goto D13)

¤ªÀÄä ªÀÄUÀÄ«UÉ PÀ©âuÁA±ÀzÀ ªÀiÁvÉæ/¹gÀ¥ï£ÀÄß 
¤Ãr¢ÝÃgÁ?  1. ºËzÀÄ   2. E®è   3. £É£À¦®è 
   (E®è/ UÉÆwÛ®è JAzÀgÉ D13PÉÌ ºÉÆÃV)
D10

Ifyes,fromwhom?ºËzÁzÀgÉ AiÀiÁjAzÀ ªÀiÁvÉæUÀ¼À£ÀÄß vÉUÉzÀÄPÉÆAr¢ÝÃj?
1.Auxiliarynursemidwife(DgÉÆÃUÀå PÁAiÀÄðPÀvÉð)
2.Anganwadiworker(DAUÀ£ÀªÁr PÁAiÀÄðPÀvÉð)
3.Healthworkeratsubcentre(¥ÁæxÀ«ÄPÀ DgÉÆÃUÀå PÉÃAzÀæzÀ DgÉÆÃUÀå PÁAiÀÄðPÀvÉð)
4.PHC(¥ÁæxÀ«ÄPÀ DgÉÆÃUÀå PÉÃAzÀæ)
5.Fromprivateshop,non­healthworkerinitiated
(SÁ¸ÀV OμÀzsÁ®AiÀÄ, ¨ÉÃgÉAiÀÄªÀgÀ §½ vÉUÉzÀÄPÉÆÃrgÀÄªÀÅzÀÄ)
6.Privatedoctor(SÁ¸ÀV ªÉÊzÀågÀÄ)
7.  Can’t remember/ Don’t know(£É£À¦®è / UÉÆwÛ®è)
D11 Howmanytabletsweregiveninlastone
year?
ªÀiÁvÉæUÀ¼À£ÀÄß ¤ÃrzÀÝgÉ PÀ¼ÉzÀ MAzÀÄ ªÀμÀðzÀ°è 
JμÀÄÖ ªÀiÁvÉæUÀ¼À£ÀÄß ¤Ãr¢ÝÃgÁ? 
1.<30(<3strips)
2.30­60(3­6strips)
3.60­90(6­9strips)
4.>90(>=9strips)
5.No.ofbottles:_________
6.None(AiÀiÁªÀÇzÀÄ E®è)
7.  Don’t know (UÉÆwÛ®è) 
D12 Howmanytabletsdidyourchild
actuallytake?
¤ÃªÀÅ ªÀiÁvÉæUÀ£ÀÄß ¤ÃrzÀÝgÉ ¤ªÀÄä ªÀÄUÀÄ JμÀÄÖ 
ªÀiÁvÉæUÀ¼À£ÀÄß £ÀÄAVzÉ. 

1.<30(<3strips)
2.30­60(3­6strips)
3.60­90(6­9strips)
4.>90(>=9strips)
5.No.ofbottles:_________
6.None(AiÀiÁªÀÇzÀÄ E®è)
7.  Don’t know (UÉÆwÛ®è)
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D13 HasyourchildeverreceivedVitaminA
liquidorcapsules?
(Interviewerprompt:visualcue)

1.Yes2.No3.Unsure
(If ‘Unsure/No’, goto D15)

¤ªÀÄä ªÀÄUÀÄ«UÉ AiÀiÁªÁUÀ¯ÁzÀgÀÆ «l«Ä£ï – 
J (EgÀÄ¼ÀÄUÀÄqÀÄvÀ£À)ªÀiÁvÉæ/¹gÀ¥ï C£ÀÄß 
¤Ãr¢ÝÃgÁ?
     1. ºËzÀÄ   2. E®è     3. £É£À¦®è       
     (E®è, UÉÆwÛ®è JAzÀgÉ D15 ºÉÆÃV)
D14 Ifyes,howmanytimesinthelastyear?

ºËzÁzÀgÉ PÀ¼ÉzÀ ªÀμÀðzÀ°è JμÀÄÖ ¨Áj 
¤Ãr¢ÝÃj? 
  
 


Don’t know (UÉÆwÛ®è)
D15 HasyourchildeverreceivedAlben­
dazoletablets?(Interviewerprompt:
visualcue)
1.Yes2.No3.Unsure

(If ‘No/Unsure’,gotoD17) 
¤ªÀÄä ªÀÄUÀÄ«UÉ AiÀiÁªÁUÀ¯ÁzÀgÀÆ dAvÀÄºÀÄ¼ÀÄ 
¤ªÁgÀPÀ  ªÀiÁvÉæUÀ¼À£ÀÄß ¤Ãr¢ÝÃgÁ?
     1.  ºËzÀÄ    2. E®è      3. £É£À¦®è 
    (E®è/UÉÆwÛ®è JAzÀgÉ D17UÉ ºÉÆÃV)
D16 Ifyes,howmanytimesinthelastyear?
ºËzÁzÀgÉ PÀ¼ÉzÀ ªÀμÀðzÀ°è JμÀÄÖ ¨Áj 
¤Ãr¢ÝÃj? 
  
Don’t know (UÉÆwÛ®è) 
    
ImmunizationHistory(ZÀÄZÀÄÑªÀÄ¢Ý£À ªÀiÁ»w)
1.Card2.PHC/Anganwadiregister
D17 Whichvaccinationshasyourchildreceived(tickthosewhichhavebeenreceived):
AiÀÄiÁªÀ AiÀÄiÁªÀ ZÀÄZÀÄÑªÀÄzÀÄÝUÀ¼À£ÀÄß ¤ªÀÄä ªÀÄUÀÄ«UÉ PÉÆr¹¢ÝÃgÁ? (PÉÆnÖgÀÄªÀ ZÀÄZÀÄÑªÀÄzÀÄÝUÀ¼À ¨ÁPÀì£À°è 
nPï ªÀiÁr). 
 0(birth) BCG HepatitisB–0 OPV–0
 6weeks(1.5mo) DPT–1 HepatitisB–1 OPV–1
 10weeks(2.5mo) DPT–2 HepatitisB–2 OPV–2
 14weeks(3.5mo) DPT–3 HepatitisB–3 OPV–3
 9months Measles VitA1stDose
 18months DPTBooster1 OPVBooster1
 VitA2nd­9thDose
(upto5years) 11/2y2y21/2y3y31/2y4y41/2y5y
 4­5years DPTBooster2 OPVBooster2 Others,Specify:
 Other
vaccinations:
Hib Specifyage/satvaccination:
 Other
vaccinations:
JapE Specifyage/satvaccination:
 Other
vaccinations:
______________ Specifyage/satvaccination:
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E. 24hourdietaryrecall(child):24 UÀAmÉUÀ¼À°è ¸ÉÃ«¹zÀ DºÁgÀzÀ ªÀiÁ»w 
 
E1.Wasyesterdayatypicaldayintermsofwhatyourchildhadtoeat?1.Yes2.No
If‘Yes’: recallyesterday’s.
        £É£Éß ¤ªÀÄä ªÀÄUÀÄ ¸ÁªÀÄ£ÀåvÀgÀºÀzÀ DºÁgÀªÀ£ÀÄß wA¢ÝvÁÛ? 
1. ºËzÀÄ   2. E®è 
       ºËzÁzÀgÉ: »A¢£À ¢£À £É£À¦¹PÉÆ½îÃ  
  
If‘No’:recallmostrecenttypicalday(writehowmanydaysago:____________)
        E¯ÁèªÁzÀ°è ¸ÁªÀÄ£ÀåvÀgÀºÀzÀ DºÁgÀªÀ£ÀÄß JμÀÄÖ ¢£ÀUÀ¼À »AzÉ wA¢ÝvÀÄÛ? 

E2.Dateofrecall:____/____/_______(dd/mm/yyyy)
£É£É¥ÀÄ ªÀiÁrPÉÆAqÀ ¢£ÁAPÀ:
Timeperiodofrecall:From______AMto______AMOilused:___________
       (¸ÀªÀÄAiÀÄ)              (J°èAzÀ)            (J°èªÀgÉUÉ)(G¥ÀAiÉÆÃV¹zÀ JuÉÚ) 
 
Areyouvegetarian/non­vegetarian?1.Veg2.Non­veg3.Veg+Egg
     ¤ÃªÀÅ ¸À¸ÀåºÁjUÀ¼É CxÀªÁ ªÀiÁA¸ÀºÁjUÀ¼É?   1. ¸À¸ÀåºÁj   2. ªÀiÁA¸ÀºÁj   3. ¸À¸Àå ªÀÄvÀÄÛ ªÀiÁA¸ÀºÁj. 
 
  Periodofconsumption
       DºÁgÀ w0zÀ ¸ÀªÀÄAiÀÄ 
Foodconsumed
¸ÉÃ«¹zÀ DºÁgÀ 
Amount(gms/ml)
¥ÀæªÀiÁt (UÁæA/«Ä°) 
Earlymorning(before
breakfast)/
ªÀÄÄAeÁ£É/wArUÉ ªÀÄÄAZÉ 




Breakfast/wAr 





Mid­morning/ wArAiÀÄ £ÀAvÀgÀ 



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  Periodofconsumption
       DºÁgÀ w0zÀ ¸ÀªÀÄAiÀÄ 
Foodconsumed
¸ÉÃ«¹zÀ DºÁgÀ 
Amount(gms/ml)
¥ÀæªÀiÁt (UÁæA/«Ä°) 
Lunch/ Hl 







Evening/¸ÁAiÀÄAPÁ® 



Dinner/ Hl 




Bedtimefood/ gÁwæAiÀÄ  
¸ÀªÀÄAiÀÄzÀ°è K£ÁzÀgÀÄ DºÁgÀªÀ£ÀÄß 
wA¢ÝvÁÛ?
 
Anyotherfooditemsduring
theday/ ¢£ÀzÀ°è ¨ÉÃgÉ K£ÁzÀgÀÄ 
DºÁgÀªÀ£ÀÄß wA¢ÝvÁÛ? 

 

F. StandardofLivingIndexQuestionnaire/ fÃªÀ£ÀªÀÄlÖ ¸ÀÆZÀåAPÀPÉÌ ¸ÀA§A¢ü¹zÀ ¥Àæ±ÉßUÀ¼ÀÄ: 
G. HygieneandSanitation/ ¸ÀéZÀÑvÉ : 
(1)Pucca: One which is built with a foundation, using stone or bricks with   and cement, having
concreteorastonelaidroof
(2)Semi­pucca:Onehouseinwhichsomecementormortarplasteringorflooringorroofingisused.
(3)Kutcha:Aconstructionwithmorethanoneroomandusingmudwallsandathatchedroof.
 Question Choosetheappropriateanswer
F1 Typeofhouse
 AiÀiÁªÀ jÃwAiÀÄ ªÀÄ£É


1.Pucca / ¥ÀPÀÌªÀÄ£É, ªÉÆ¯ïØ ªÀÄ£É  
2.Semi­pucca/ ºÉAa£À ªÀÄ£É
3.Katcha/ UÀÄr¸À®Ä             
F2 Doesthishouseholdownthis
houseoranyotherhouse?  
J®èzÀgÀÆ ¸ÀéAvÀ ªÀÄ£É EzÉAiÉÄÃ?
1.Yes/ºËzÀÄ 
2.No/E®è 
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 Question Choosetheappropriateanswer
F3 Doyouhaveaseparateroomfor
kitchen?/ ¤ªÀÄä ªÀÄ£ÉAiÀÄ°è CqÀÄUÉ 
PÉÆÃuÉ ¨ÉÃgÉAiÀiÁV EzÉAiÉÄÃ?
1.Yes/ ºËzÀÄ 
2.No/ E®è
F4 Whattypeoffueldoesyour
householdmainlyusefor
cooking? 
¤ªÀÄä ªÀÄ£ÉAiÀÄ°èCqÀÄUÉ ªÀiÁqÀ®Ä AiÀiÁªÀ 
EAzsÀ£ÀªÀ£ÀÄß §¼À¸ÀÄwÛÃgÁ? 
1. Wood/PÀnÖUÉ
2. Cropresidues/¨É¼É¬ÄAzÀ§AzÀ PÀrØUÀ¼ÀÄ 
3. Dungcakes/¨ÉgÀtÂ 
4. Coal/coke/lignite/ PÀ°èzÀÝ®Ä, PÉÆÃPï, °UÉßÃmï 
5. Charcoal/ PÀ°èzÀÝ®Ä 
6. Kerosene/¹ÃªÉÄJuÉÚ
7. Electricity/«zÀÄåvï
8. LPG/ UÁå¸ï 
9. Bio­gas/ eÉÊ«PÀ EAzsÀ£À


G1.Doyouwashyourhandsbeforepreparingameal?
     ¤ÃªÀÅ CqÀÄUÉ ªÀiÁqÀÄªÀ ªÀÄÄAZÉ ¤ªÀÄä PÉÊUÀ¼À£ÀÄß vÉÆ¼ÉAiÀÄÄwÛÃgÁ1.Yes/ ºËzÀÄ2.No/ E®
G2.Doesyourchildwashhandsbeforeeating?
     ¤ªÀÄä ªÀÄUÀÄ Hl w£ÀÄßªÀ ªÉÆzÀ®Ä PÉÊ vÉÆ¼ÉAiÀÄÄvÀÛzÀ?            1.Yes/ ºËzÀÄ2.No/ E®
 
 
 
 
 Question Choosetheappropriateanswer
F5 Howmuchagriculturelanddoes
thishouseholdown?
 ¤ªÀÄUÉ PÀÈ¶ d«ÄÃ£ÀÄ J¶ÖzÉ?
1.5acresormore/5 JPÀgÉVAvÀ  ºÉZÀÄÑ       
2.2to4.9acres/ 2jAzÀ 5 JPÀgÉ
3.<2acres/unknownacreage
(2 JPÀgÉVAvÀPÀrªÉÄ / UÉÆwÛ®è) 
4.Noland/ d«ÄÃ£ÀÄ E®è (If ‘No land’ goto F7)
F6 Outofthisland,howmuchis
irrigated?/ EμÀÄÖ d«ÄÃ¤£À°è JμÀÄÖ 
¤ÃgÁªÀj d«ÄÃ£ÀÄ EzÉ
1. All/Some J¯Áè/¸Àé®à 
2. None/Don’t know 
      AiÀiÁªÀÅzÀÄ E®è/ UÉÆwÛ®è
F7 Doesthishouseholdownany
livestock? ¤ªÀÄä ªÀÄ£ÉAiÀÄ°è AiÀÄªÀÅzÁzÀgÀÄ 
eÁ£ÀÄªÁgÀÄUÀ¼ÀÄ EzÉAiÉÄÃ?
1. Yes/ ºËzÀÄ 
2. No/ E®è
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 Question Choosetheappropriateanswer
F8 Whatisthemainsourceof
lightingforyourhousehold? ¤ªÀÄä 
ªÀÄ£ÉAiÀÄ°è ¨É¼ÀQUÁV AiÀiÁªÀÅzÀ£ÀÄß 
G¥ÀAiÉÆÃV¸ÀÄwÛÃgÁ?
1. Electricity/«zÀÄåvï 
2. Kerosene/¹ÃªÉÄJuÉÚ 
3. Gas/UÁå¸ï 
4. Candle/oilªÀÄÄA§wÛ/JuÉÚ 
 Question Choosetheappropriateanswer
F9 Whatisthemainsourceof
drinkingwaterformembersof
yourhousehold?/ ¤ªÀÄä 
ªÀÄ£ÉAiÀÄ°ègÀÄªÀªÀjUÉ PÀÄrAiÀÄÄªÀ ¤ÃjUÁV 
AiÀiÁªÀ ªÀåªÀ¸ÉÜ EzÉ?
 Pipedwater(£À°èAiÀÄ ªÀÄÄSÁAvÀgÀ) 
1. Residence/yard/Plot
    (ªÀÄ£É, ºÉÆgÀUÉ, ªÀÄ£ÉAiÀÄ CUÀvÀå«gÀÄªÀ PÀqÉ)
2. Publictank(¸ÁªÀðd¤PÀ £À°è)
 Groundwater/ CAvÀdð®
3. Handpumpatresidence/yard/plot
(ºÁåAqï ¥ÀA¥ï)
4.Publichandpump(¸ÁªÀðd¤PÀ ºÁåAqï ¥ÀA¥ï) 
 Wellwater (¨Á« ¤ÃgÀÄ)
5.Residence,yard,plot(ªÀÄ£ÉAiÀÄ M¼ÀUÉ)
6.Coveredwell (ªÀÄÄaÑzÀ ¨Á«) 
7.Openwell (vÉgÉzÀ ¨Á«) 
8.Publicwell(¸ÁªÀðd¤PÀ ¨Á«) 
 Surfacewater 
9.Spring(fV/aªÀÄÄä) 
10.River/Stream(ºÀjAiÀÄÄªÀ ¤ÃgÀÄ)
11.Pond/Lake(PÉgÉ) 
12.Dam (¸ÀAUÀæºÀªÁVgÀÄªÀ PÉgÉ)
 13.Rainwater (ªÀÄ¼ÉAiÀÄ ¤ÃgÀÄ) 
 14.Tankertruck (ºÉÆgÀUÀqÉ¬ÄAzÀ ¤ÃgÀÄ vÀj¸ÀÄªÀÅzÀÄ)
F10 Whatkindoftoiletfacilitydoes
yourhouseholdhave?  
 
¤ªÀÄä ªÀÄ£ÉAiÀÄ°è AiÀiÁªÀ jÃwAiÀÄ ±ËZÁ®AiÀÄ 
ªÀåªÀ¸ÉÜ ¬ÄzÉ?
 Flushtoilet/Latrine(¥sÀè±ï/¤Ãj£À ªÀåªÀ¸ÉÜ EgÀÄªÀ 
±ËZÁ®AiÀÄ)  
1.Ownflushtoilet(¸ÀéAvÀ)
2.Sharedflushtoilet(ºÀAaPÉAiÀÄ) 
3.Publicflushtoilet (¸ÁªÀðd¤PÀ)
 Pittoilet/Latrine(EAUÀÄ UÀÄAr)
4.Ownpittoilet(¸ÀéAvÀ)
5.Sharedtoilet(ºÀAaPÉAiÀÄ) 
6.Publictoilet(¸ÁªÀðd¤PÀ) 
 7.Nofacilityavailable(GototoG6)
(±ËZÁ®AiÀÄ E®è)
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
PID


G3 Doesthischildusethetoiletroutinely?
¤ªÀÄä ªÀÄPÀÌ¼ÀÄ ¤gÀAvÀgÀªÁV ±ËZÁ®AiÀÄ §¼ÀPÉ 
ªÀiÁqÀÄvÁÛgÉAiÉÄ? 
 
1.Yes2.No
1. ºËzÀÄ       2. E®è
G4 Doesyourchildwearfootwearwhengoing
out?¤ªÀÄä ªÀÄUÀÄ ºÉÆgÀUÉ ºÉÆÃUÀÄªÁUÀ ZÀ¥Àà°UÀ¼À£ÀÄß 
zsÀj¸ÀÄvÀÛzÉÃAiÉÄÃ?

1.Yes2.No
1. ºËzÀÄ       2. E®è
 
F11 Doesthehouseholdownanyoneofthefollowing:
 ¤ªÀÄä ªÀÄ£ÉAiÀÄ°è F PÉ¼ÀPÀAqÀ ªÀ¸ÀÄÛUÀ¼ÀÄ EªÉAiÉÄÃ?
Yes/ No 
ºËzÀÄ/ E®è 
(Circleifowned)
1. ABed / ºÁ¹UÉ  Yes/ No
2. APressurecooker/ PÀÄPÀÌgï Yes/ No
3. AChair/ PÀÄað Yes/ No 
4. ACot/ ªÀÄAZÀ  Yes/ No 
5. ATable/¨ÉAZÀÄ Yes/ No 
6. AClock/UÉÆÃqÉ UÀrAiÀiÁgÀ Yes/ No 
7. AWristwatch/ PÉÊUÀrAiÀiÁgÀ Yes/ No 
8. ACycle/ ¨ÉÊ¹PÀ¯ï Yes/ No 
9. ARadio/transistor/gÉÃrAiÉÆÃ Yes/ No 
10. ATailoringmachine/ ºÉÆ°UÉ AiÀÄAvÀæ Yes/ No 
11. Alandline/mobilephone/ zÀÆgÀªÁtÂ Yes/ No 
12. AFridge/ gÉ¦üæfgÉÃlgï Yes/ No 
13. ABlack&whiteTV/ PÀ¥ÀÄà ©¼ÀÄ¥ÀÄ n.« Yes/ No 
14. AColourTV/§tÚzÀ n.« Yes/ No 
15. ATwowheeler/¸ÀÆÌlgï, ªÉÆÃmÁgï Yes/ No 
16. ACar/ PÁgï Yes/ No 
17. AWaterpump/ ¤Ãj£À ¨Á« Yes/ No 
18. ABullockcart/ JwÛ£À UÁr Yes/ No 
19. ATractor/ mÁæöåPÀÖgï Yes/ No 
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

H. Anthropometricdetails:




Child

BirthWeight(kg): 
Weight(kg): 
Height/Length(cm): 
Midupperarmcircumference(cm): 
Headcircumference(cm): 


I.Laboratoryinvestigations:samplecollectionchecklists
I1.Child:
Sl.no. Sample Samplecollected
Sample
volume
1. Blood:2mlEDTAvacutainer(purpletop) 1.Yes 2.No ml
2. Blood:1mlSerumvacutainer(yellowtop) 1.Yes 2.No ml
3. Urine:10mlurineinsterileurinecontainer 1.Yes 2.No ml

I2.Mother:
Sl.no. Sample Samplecollected
Sample
volume
1. Blood:2mlEDTAvacutainer(purpletop) 1.Yes 2.No ml
2. Blood:1mlSerumvacutainer(yellowtop) 1.Yes 2.No ml
3. Urine:10mlurineinsterileurinecontainer 1.Yes 2.No ml


$33(1',;% KAP2
BASELINEINVESTIGATIONREPORT
(Completedbyresearchteamatbaselineandgiventomothers)
Date:
VillageID PID (dd) (mm) (yyyy)
 ºÀ½îAiÀÄ ¸ÀASÉå      ¸ÀASÉå    ¢£ÁAPÀ: 
Villagename:
_______________________
Activity
done
Interview/Labs QC Data
Entry1
Data
Entry2
Personnel
Initials
Date
NameoftheChild:______________________
Age :______________________Weight(kg):______Height(cm):_______
AnganwadiRollNo.:_______________________
NameoftheMother:________________________
CHILD(ªÀÄUÀÄ):
Haematology Results Haematology Results
Hemoglobin(g/dl) MCV(fl)
TotalRBCcount(x106/μL) MCH(pg)
TotalWBCcount(x103/μL) MCHC(g/dl)
Platelets(x103/μL) RDW(%)
ChildreferredtoPHCforfurthercare: 1. Yes 2. No
MOTHER(vÁ¬Ä):
Haematology Results Haematology Results
Hemoglobin(g/dl) MCV(fl)
TotalRBCcount(x106/μL) MCH(pg)
TotalWBCcount(x103/μL) MCHC(g/dl)
Platelets(x103/μL) RDW(%)
MotherreferredtoPHCforfurthercare: 1. Yes 2. No
__________________
SignatureoftheProjectCo­ordinator
Dr.VidyaChellaswamy
$33(1',;& KAP2
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ADHERENCEFORM­ANEMIC
(CompletedbyLHWforanemicchildrenininterventionarmintheendofeverymonth)
Date:
VillageID PID (dd) (mm) (yyyy) 
    ºÀ½îAiÀÄ ¸ÀASÉå  ¸ÀASÉå  ¢£ÁAPÀ: 
Villagename:
___________________
Activity
done Interview QC
Data
Entry1
Data
Entry2
Personnel
Initials
Date
Thisquestionnaireisfilledupinthefollow­upmonth:
A.IsthechildreceivingIFA? 1. Yes 2. No(if‘No’,gotoC)
DetailsofIFAtabletsdispensedforlastmonth:
NumberofIFA
tabletsdispensed Dateofdispensation Dispensedto
NumberofIFA
tabletsremaining
withmother
1. Mother
2. Others:
__________
B.IfthechildhasmissedIFAdoses,whatmaybethereasonsfordoingso?(donotprobe)
Q.No. Questions Ticktheboxes
1. Childhadsideeffects/wantedtoavoidsideeffects
2. DidnotgetthetabletsfromtheLHW/ranoutofpills
3. DidnotknowwhyIFAtabletswereimportant
4. Forgottogivethechildthetablets
5. Religiousdietaryrestrictions/communitybeliefs
Form4­16thSeptember2014  KAP2
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Q.No. Questions Ticktheboxes
6. Wentawayfromhomeforholidays 
7. Suspectedthequalityofgovernmentsuppliedtablets 
8. Childrefused/difficulttogetthechildtotakeIFAtablets. 
9. Tabletswerelost/misplaced 
10. Others,specify:
________________________________________________




C.Checklist:

Sl.No. Counsellingtopics
Tickif
counselled
1.  Symptomsandsignsofanemia 
2.  TreatmentwithIFA,itssideeffects,monitoringofcompliance 
3.  Sourcesoflocalironrichfoodsanddietarydiversification 
4.  Personalhygieneandvalueofdeworming

5. Repeattestingtoseeeffectoftreatmentofanemia


$33(1',;' KAP2
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ADHERENCEFORM–NONANEMIC&CONTROL
(CompletedbyLHWforallnon­anemicparticipantininterventionarm&
allchildrenincontrolarmattrialclosure)
Date:
VillageID PID (dd) (mm) (yyyy) 
 ºÀ½îAiÀÄ ¸ÀASÉå     ¸ÀASÉå  ¢£ÁAPÀ: 
Villagename:
___________________
Activity
done Interview QC
Data
Entry1
Data
Entry2
Personnel
Initials
Date
A.IstheChildreceivingIFA?1. Yes 2. No(if ‘Yes’ fill the details below)
DetailsofIFAtabletsdispensedduringthepreviousmonth:
NumberofIFA
tabletsdispensed Dateofdispensation Dispensedto
NumberofIFAtablets
remainingwithmother
(Instructthemotherstobringthe
remainingpillsalongwiththem)
<8permonth
>8permonth
1. Mother
2. Others:
__________
B.IfthechildhasmissedIFAdoses,whatmaybethereasonsfordoingso?(donotprobe)
Q.No. Questions Ticktheboxes
1. Childhadsideeffects/wantedtoavoidsideeffects
2. DidnotgetthetabletsfromtheLHW/ranoutofpills
3. DidnotknowwhyIFAtabletswereimportant
4. Forgottogivethechildthetablets
5. Religiousdietaryrestrictions/communitybeliefs
6. Wentawayfromhomeforholidays
7. Suspectedthequalityofgovernmentsuppliedtablets
8. Childrefused/difficulttogetthechildtotakeIFAtablets.
9. Tabletswerelost/misplaced
10. Others,specify:
____________________________________________________
Characteristics of non-participants compared with recruited baseline participants enrolled in 
the KAP 2 study, Chamarajnagar district, Karnataka.  
Baseline characteristics Non- 
participants 
(Control) 
n=226 
Participants 
(Control)  
n=536 
Non-
participants 
(Intervention) 
n=195 
Participants 
(Intervention) 
n=608 
Reason for not 
participating  (%) 
    Travelling/work 174 (76.9) 152 (77.9) 
    Migrated 44 (19.5) 36 (18.5) 
    Reported sick 5 (2.2) 5 (2.6) 
    Other 3 (1.3) 2 (1.0) 
Child’s age months,  
mean (SD)  
32.0 (12.8) 34.8 (12.0) 33.1 (13.4) 35.3 (12.8) 
Sex 
    Female (%) 53 52 54 53 
    Male (%) 47 48 46 47 
Maternal  age, mean 
(SD)
26.0 (3.8) 25.0 (3.5) 26.0 (3.9) 24.7  (3.4) 
Maternal  education,  
mean (SD)
8.4 (3.5) 8.1 (3.9) 7.4 (4.1) 7.3 (3.9) 
SD  standard deviation 
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Characteristics of non-participants compared with recruited baseline participants enrolled in 
the KAP 2 study, Chamarajnagar district, Karnataka.  

